The QualityStocks Daily Thursday, October 17th, 2019

Today's Top 3 Investment Newsletters

QualityStocks (ACLZ) +88.44%

StockMarketWatch (PLX) +74.03%

CannabisNewsWire (MCOA) +47.04%

The QualityStocks Daily Stock List

Celexus, Inc. (CXUS)

Last10k, Stockwatch, Market Screener, Stockopedia, TeleTrader, Street Insider, PR Newswire, Invest Tribune, OTC Markets, InvestorsHub, Investors Hangout, TradingView, Wallet Investor, Dividend Investor, Simply Wall St, Stockhouse, and GlobeNewswire reported earlier on Celexus, Inc. (CXUS), and today we report on the Company, here at the QualityStocks Daily Newsletter.

Celexus, Inc. is an acquisition, management and holding company for high-trajectory agritech businesses and farming technologies. The Company was formerly known as Telupay International, Inc. As of February 2019, Celexus has agreed to acquire HempWave and operate it as a wholly-owned subsidiary. HempWave partners with farmers throughout the nation to grow, cultivate, and harvest commercial-grade hemp plants and seeds to produce medicinal grade cannabidiol (CBD oils) and other hemp by-products. HempWave is an Arizona-based farming accelerator and sustainability catalyst. Celexus lists on the OTC Markets’ OTCQB.

Celexus operates as an acquisition, management, and holding company for early stage businesses and technologies in the hemp industry. It works to bring to market the best, most valuable innovations in the flourishing industrial hemp space. The Company is actively assessing new acquisition candidates across the agriculture industry. Its aim is to control every aspect of the farming industry. This is from seeds to extraction and distribution. This eliminates reliance on third parties and ensures premier quality processes and production.

HempWave announced in June 2019 that it acquired all five of the industrial hemp licenses available from the State of Arizona. This is licensure that makes HempWave one of the first vertically integrated hemp companies in Arizona. HempWave physically acquired each of the five respective commercial hemp licenses from Arizona - Nursery, Grower, Harvester, Transporter, and Processor - on May 31, 2019, the first day the licenses were available.

HempWave also announced in June that it entered into agreements with four large-scale farming operations in Arizona. These agreements will allow it to grow and harvest industrial hemp on more than 600 acres this year. HempWave's four initial commercial hemp farms will be based in Arizona's Gila River Valley, as well as in the cities of Eloy and Willcox.

In August, HempWave announced that it started planting its first fields in Arizona in partnership with industrial farms. The planting marks the first of manifold successful joint ventures (JVs) for HempWave with Arizona farms transitioning to industrial hemp.

Celexus and HempWave have a partnership with Sucseed to support co-working/co-growing greenhouse opportunities. Sucseed is a division of Central Business Development. It is a California-based industrial hemp incubator and accelerator. Sucseed’s unique and customizable model allows individuals and companies to lease space from “grow tables” in a cooperative greenhouse or entire greenhouse sections for larger full-term grows.

Celexus, Inc. (CXUS), closed Thursday's trading session at $0.4009, off by 33.1833%, on 7,002 volume with 5 trades. The average volume for the last 3 months is 2,559 and the stock's 52-week low/high is $0.188999995/$1.95299994.

chart

Energy and Water Development Corp. (EAWD)

PR Newswire, Nasdaq, Stockopedia, Seeking Alpha, GlobeNewswire and Market Screener reported previously on Energy and Water Development Corp. (EAWD), and we highlight the Company as well, here at the QualityStocks Daily Newsletter.

Energy and Water Development Corp. is a green-tech engineering solutions company listed on the OTC Markets. Its emphasis is on delivering water and energy to extreme environments. The Company builds water and energy systems out of already-existing, proven technologies, using its technical knowledge to customize solutions to their clients’ needs. Energy and Water Development is based in Miami, Florida.

Last month, Eurosport Active World Corporation (EAWD) announced its name change to Energy and Water Development Corp. This is to better reflect its aforementioned business strategy of operating a green-technology engineering solutions company centered on delivering water and energy to extreme environments.

Mr. Ralph Hofmeier, Chief Executive Officer, said, “The name change is the first in a series of steps we are taking to align our marketing and branding strategies to more accurately reflect our business.”

Energy and Water Development offers design, construction, maintenance, and specialty consulting services to private companies, government entities, and non-government organizations (NGOs). The Company has acquired the relevant licenses that give it the right to sell and produce the associated technologies while ensuring, via its partnership with Swiss Water Tech R&D, the provision of related services. These services include Research & Development, technical maintenance; education; and training.

Energy and Water Development has turnkey technologies from Germany and other European nations. It also has turnkey solutions with considerable potential for growth globally. Moreover, the Company has clean, energy-and-cost saving solutions that are easy to install; mobile; self-contained; and built to last. Furthermore, it has Carbon Tax-Free Projects. Energy and Water Development’s advantage is having worldwide distributor licenses, patents, and the advantage of German and other European technologies.

In April 2019, the Company announced that an agreement was signed to lease its Atmospheric Water Generation technological solutions by way of lease programs in South Africa. It announced in March 2019 the launching of The Blue Aqua Mission™ System. This is a state-of-the-art German engineered Atmosphere Water Generation (AWG) technology that is totally powered by renewable energy. This system consists of a suite of intelligent software solutions for real-time optimization of process performance, and operates through its own inventive self-powered system.

Energy and Water Development Corp. (EAWD), closed Thursday's trading session at $0.15, off by 16.6667%, on 11,300 volume with 3 trades. The average volume for the last 3 months is 23,192 and the stock's 52-week low/high is $0.144999995/$3.75.

chart

Grayscale Bitcoin Trust (GBTC)

Zacks, Coindesk, Bitcoin Exchange Guide, CryptoCurrency Facts, Altcoin Buzz, InvestorsHub, Insider Financial, Trading View, Street Register, Stockopedia, and Bitcoinist reported beforehand on Grayscale Bitcoin Trust (GBTC), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Grayscale Investments is the world’s largest digital currency asset manager. The Company is an international leader in digital currency asset management. Its flagship asset is Grayscale Bitcoin Trust. Grayscale Investments provides opportunities for investors to gain exposure to digital currencies. Its Grayscale Bitcoin Trust provides direct exposure to Bitcoin by way of a traditional investment vehicle. Grayscale is based in New York, New York and the Company lists on the OTC Markets Group’s OTCQX.

Grayscale Investments is part of Digital Currency Group. The Company accesses the world’s largest network of industry intelligence to build better investment products. Grayscale has removed the barrier to entry so that institutions and individual investors can benefit from exposure to digital currencies. Astute investors can partake of the digital future with an institutional grade investment.

In January 2019, Grayscale Investments announced that it launched Grayscale Stellar Lumens Trust. This is the first single-asset investment product that provides exposure to Lumens (XLM), the native asset of the Stellar network. This is the ninth single-asset investment product introduced by Grayscale Investments. Furthermore, the Company manages Grayscale Digital Large Cap Fund™. This is a diversified investment product. It provides exposure to the leading digital currencies by market capitalization.

Grayscale Investments announced in May of this year that common units of fractional undivided beneficial interest (Shares) in Grayscale Ethereum Trust™ (ETHE) were approved by FINRA for a public quotation (Symbol: ETHE) on the OTC Markets. ETHE was launched in 2017 and is sponsored by Grayscale. ETHE is an open-ended trust. It holds Ethereum and derives its value exclusively from the value of Ethereum.

Investors in ETHE can gain exposure to the price movement of Ethereum without the challenges of buying, storing, and safekeeping Ethereum. ETHE will not generate any income. It regularly distributes Ethereum to pay for its ongoing expenses. Therefore, the amount of Ethereum represented by each Share gradually decreases over time.

This week, Grayscale Investments® released its Q3 2019 Grayscale Digital Asset Investment Report. This is a wide-ranging report that highlights investment activity and performance across the Grayscale family of products from July 1, 2019 through September 30, 2019. During Q3 of 2019, Grayscale raised $254.9 million into its investment products, triple the assets raised during Q2, when it raised $84.8 million.

The inflows mark Grayscale’s strongest quarterly asset raise since the firm’s inception. Grayscale® Bitcoin Trust led investment demand with $171.7 million in inflows. This represents the greatest quarterly inflows into the Trust during the product’s six-year history.

Grayscale Bitcoin Trust (GBTC), closed Thursday's trading session at $8.97, up 2.3973%, on 2,073,276 volume with 3,316 trades. The average volume for the last 3 months is 3,478,701 and the stock's 52-week low/high is $3.66000008/$17.3999996.

chart

Kraig Biocraft Laboratories, Inc. (KBLB)

Super Stock Screener, Infront Analytics, TradingView, InvestorsHub, Investor Village, Stock Pulse, TipRanks, Discovery Stocks, Emerging Growth, Stockhouse, Wallet Investor, Insider Financial, and Simply Wall St reported beforehand on Kraig Biocraft Laboratories, Inc. (KBLB), and today we report on the Company, here at the QualityStocks Daily Newsletter.

Kraig Biocraft Laboratories, Inc. is the foremost developer of genetically engineered spider silk based fibers. The Company has attained a series of scientific breakthroughs in the area of spider silk technology with implications for the global textile industry. Its genetic engineering research has succeeded in developing what many consider to be the holy grail of material science – a practical and cost-effective technology for producing recombinant spider silk based fibers on an industrial scale. Spider Silk is among the strongest fibers produced in nature. OTCQB-listed, Kraig Biocraft Laboratories is headquartered in Ann Arbor, Michigan.

The Company obtained at its inception, proprietary genetic engineering technology to unlock the mystery of producing spider silk. In early 2006, it obtained certain exclusive rights from the University of Wyoming to use the spider silk gene sequences in its field of use. At present, it is ramping up production of its Monster Silk™ and Dragon Silk™ for commercialization. In addition, it is continuing to develop new and recombinant spider silk fibers.

Polartec and Kraig Biocraft Laboratories announced in April 2019 plans to bring to market the first fabrics made from spider silk. Initially developed for specialized military applications, these first-of-their- kind materials made from recombinant spider silk will ultimately service the worldwide market for high performance textiles and apparel. Polartec is the premium provider of innovative and sustainable textile solutions.

Kraig Biocraft Laboratories has created a next generation of recombinant spider silk using its new design, gene editing, and incorporation approaches. Kraig Labs designed this approach to customize mechanical properties for specific commercial markets. It has demonstrated the ability to more quickly, accurately, and efficiently generate new transgenics.

Last week, Kraig Biocraft Laboratories announced that it officially started commercial production scale-up of its recombinant spider silk production at its Vietnamese subsidiary, Prodigy Textiles. During a trip last week, Mr. Jon Rice, the Company’s Chief Operating Officer, successfully delivered Kraig Biocraft Laboratories’ specialized silkworm eggs to the production team, at Prodigy Textiles’ recently renovated factory.

The Company said that this moment marks a pivotal milestone in the commercialization and production of eco-friendly and cost effective recombinant spider silk. With capacity scale up now officially underway in Vietnam, Kraig Biocraft Laboratories is centered on the production of its recombinant spider silk threads and yarns for delivery to collaborative partners and target market segments.

Kraig Biocraft Laboratories, Inc. (KBLB), closed Thursday's trading session at $0.21, off by 4.5455%, on 695,446 volume with 81 trades. The average volume for the last 3 months is 2,188,687 and the stock's 52-week low/high is $0.035199999/$0.507000029.

chart

PolyNovo Limited (CALZF)

All Stocks Today, AAStocks, TipRanks, Trade Ideas, OTC Markets, Dividend.com, Market Screener, InvestingOnline.com, TradingView, Seeking Alpha, 4-Traders, MarketWatch, InvestorsHub, Nasdaq, Wallmine, Simply Wall St, Morningstar, GuruFocus, Dividend Investor, and Wallet Investor reported earlier on PolyNovo Limited (CALZF), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

PolyNovo Limited is the developer of innovative patented, biodegradable polymers for use in medical devices. The Company’s vision is to provide unique and inventive regenerative products for burns, surgical wounds, hernia repair, trauma, orthopaedics and reconstructive surgery. The Company previously went by the name Calzada Limited. It changed its name to PolyNovo Limited in November of 2014. PolyNovo is based in Port Melbourne, Australia.

The Company designs, develops, and manufactures dermal regeneration solutions in the U.S, Australia, New Zealand, and worldwide. PolyNovo concentrates on the development and commercialization of medical devices employing its NovoSorb technology in the treatment of burns, surgical wounds, and negative pressure wound therapy.

PolyNovo offers BTM (Biodegradable Temporising Matrix). This is a wound dressing intended for the treatment of full-thickness wounds and burns. Furthermore, the Company licensed its NovoSorb to Smith & Nephew for orthopaedic applications.

Fiscal Year (FY) 2019 was a pivotal year for the Group with sales from NovoSorb BTM increasing 435 percent over the previous year. PolyNovo reported Revenue for year ended June 30, 2019 of $13.683 million. This represents an increase of 128 percent from FY 2018 $5.989 million.

The Company’s U.S. sales infrastructure grew with the addition of new sales and marketing people. As at the end of August 2019, the PolyNovo Group had 20 sales people and 5 marketers. The Company anticipates more sales roles to be added in the United Kingdom and Ireland and U.S. as sales increase. Moreover, in the period, PolyNovo gained approval to sell NovoSorb BTM to the US Department of Defence and Veteran Affairs.

NovoSorb BTM is registered for use in the USA, Australia, New Zealand, South Africa, Malaysia, India, Israel and Saudi Arabia. NovoSorb is a novel range of bio-resorbable polymers. These can be produced in numerous formats including, film, fibre, foam, and coatings. NovoSorb’s innovative properties provide premier biocompatibility, control over physical properties, and programmable bio-resorption profile.

The Company’s Australia/European burn trial has been completed. PolyNovo will publish the results of the study by the end of Calendar Year 2019. Moreover, the Company’s new Hernia products have progressed to commercial scale up.

PolyNovo Limited (CALZF), closed Thursday's trading session at $1.85, up 20.915%, on 20,300 volume with 4 trades. The average volume for the last 3 months is 8,179 and the stock's 52-week low/high is $0.38499999/$2.15000009.

chart

Simplicity Esports and Gaming Company (WINR)

Penny Stock Base, Investor Ideas, GlobeNewswire, and MarketWatch reported previously on Simplicity Esports and Gaming Company (WINR), and today we report on the Company, here at the QualityStocks Daily Newsletter.

Simplicity Esports and Gaming Company is an established brand in the esports industry. The Company has an engaged fan base competing in popular games across diverse genres. These include PUBG, Fortnite, League of Legends, Overwatch, Gears of War, Smite, and many EA Sports titles. The Company formerly went by the name Smaaash Entertainment, Inc. It changed its corporate name to Simplicity Esports and Gaming Company in January of 2019. Incorporated in 2017, Simplicity Esports and Gaming is based in New York, New York and lists on the OTCQB.

The Company also operates Esports Gaming Centers. These provide the public an opportunity to experience and enjoy gaming and esports in a social setting, regardless of skill or experience. In essence, Simplicity Esports and Gaming is a global virtual reality gaming and fully integrated eSports platform company.

It is an emerging operator and developer of family entertainment centers throughout the USA, combining proprietary sports, eSports, virtual and augmented reality gaming and also dining into a highly interactive and innovative social experience for family and friends. The Company’s totally integrated eSports platform concept will include the development of dedicated eSports centers nationwide, alongside the management of eSports teams at all competitive levels.

In September, Simplicity Esports and Gaming Company announced that it expects to have 85 esports gaming centers by the end of 2020. Mr. Jed Kaplan, Chief Executive Officer of the Company, stated, “We’ve had a significant surge in the number of qualified franchisee applicants since the PLAYlive Nation acquisition. We believe our nationwide footprint of esports gaming centers provides potential franchisees an attractive opportunity to co-invest, alongside Simplicity Esports, and actively engage in the esports industry at a time when there are limited options for investing in esports companies. We expect to have 55 locations in operation by the end of 2019, and 85 locations in operation by the end of 2020.”

This past July, Simplicity Esports and Gaming Company announced that it closed the earlier announced acquisition of PLAYlive Nation, Inc. PLAYlive has a network of 44 franchised Gaming Centers throughout 11 States, including but not limited to, California, Washington, Arizona, and Texas, serving more than 150,000 unique gamers each year. PLAYlive Centers are highly complementary to Simplicity Esports Gaming Centers, which offer gamers a specialized entertainment gaming experience within a social setting.

Simplicity Esports and Gaming Company (WINR), closed Thursday's trading session at $2.08, up 4.00%, on 1,015 volume with 12 trades. The average volume for the last 3 months is 3,996 and the stock's 52-week low/high is $0.560000002/$11.0500001.

chart

Xebec Adsorption, Inc. (XEBEF)

Street Insider, Proactive Investors, OTC Markets, Investor Ideas, Midas Letter, Wallet Investor, Stockhouse, Nasdaq, TradingView, PR Newswire, Canadian Insider, Investors Hangout, Market Screener, Morningstar, Seeking Alpha, Stockwatch, GlobeNewswire, and MarketWatch reported previously on Xebec Adsorption, Inc. (XEBEF), and we also highlight the Company, here at the QualityStocks Daily Newsletter.

Xebec Adsorption, Inc. is a worldwide provider of clean energy solutions. The Company provides gas generation, purification and filtration solutions for the industrial, energy and renewables marketplace. Xebec has proprietary technologies that transform raw gases into clean sources of renewable energy. Xebec Adsorption has its corporate headquarters in Blainville, Quebec. In addition, it has a number of Sales and Support offices in North America and Europe, and also two manufacturing facilities in Montréal and Shanghai. The Company’s shares trade on the OTC Markets Group’s OTCQX.

Xebec Adsorption’s head office in Blainville, Quebec is a 41,753 square foot manufacturing facility. The Blainville operation houses corporate finance, sales and application support, filtration and aftermarket, worldwide supply chain, operational engineering, manufacturing and service and maintenance support.

The Company’s Asian 20,451 square foot manufacturing facility is in the Song Jiang district of Shanghai, China. This facility is responsible for sales, product engineering and assembly using components manufactured in the greater Shanghai industrial area. Moreover, this facility provides shared services. This includes supply chain and engineering support to Xebec’s head office. Additionally, Xebec Shanghai is responsible for sales of Xebec’s products, marketing, technical and after-sales support for the Asian and South East Asian markets.

Xebec Adsorption has more than 1500 customers. These customers range from small to multi-national corporations, governments and municipalities looking to decrease their carbon footprints.

Xebec Adsorption designs, develops, builds, sells, and services a range of pressure swing adsorption and membrane gas purification systems for biogas purification (BGX Solutions™); natural gas dehydration and conditioning units for natural gas vehicle refueling stations and for natural gas upgrading (NGX Solutions™); hydrogen purification pressure swing adsorption (PSA) systems (H2X Solutions™); helium purification systems (SGX Solutions™); field gas or associated gas purification systems (AGX Solutions™); and filtration and separation equipment (FSX Solutions™).

This past July, Xebec Adsorption announced its inclusion in the U.S. Department of Energy’s (DOE) US$24 million commitment to a public-private collaboration funding 77 energy technology projects. With matching funds from the private sector, the Office of Technology Transition’s (OTT) Technology Commercialization Fund (TCF) will advance the commercialization of promising energy technologies. It will also strengthen partnerships between DOE’s National Laboratories and private sector companies to deploy these technologies to the marketplace. Xebec Adsorption is a supporting Industrial partner on this project because of its collaboration with Southern California Gas (SoCalGas), and a California treatment facility.

Last month, Xebec Adsorption announced it closed a number of contracts the past month totaling roughly CDN$11.7 million. These orders span the breadth of the Company’s capabilities - from renewable natural gas (RNG) generation through several hydrogen purification projects. These include a fuel cell fueling application, syngas purification from waste gasification, and CO2 capture and use.

Xebec Adsorption, Inc. (XEBEF), closed Thursday's trading session at $1.25, up 10.239%, on 1,130 volume with 3 trades. The average volume for the last 3 months is 1,452 and the stock's 52-week low/high is $0.499099999/$2.00.

chart

Uniroyal Global Engineered Products, Inc. (UNIR)

NetworkNewsWire, StockPulse, Zacks, Simply Wall St, Infront Analytics, Wallet Investor, Stockhouse, Proactive Investors, Capital Network, Proactive Investors, Market Screener, and OTC Markets reported previously on Uniroyal Global Engineered Products, Inc. (UNIR), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Uniroyal Global Engineered Products, Inc. (UNIR) is a worldwide provider of vinyl coated fabrics products that have diverse high performance characteristics and capabilities. These products are manufactured by the Company’s subsidiaries Uniroyal Engineered Products, LLC and Uniroyal Global Limited. UNIR is a foremost manufacturer of vinyl-coated fabrics, which are durable, stain resistant, cost-effective alternatives to leather, cloth and other synthetic fabric coverings. OTCQB-listed, UNIR is headquartered in Sarasota, Florida.

The Company’s coated fabrics products are frequently used in applications that require rigorous performance characteristics. These include automotive and non-automotive transportation, certain indoor/outdoor furniture, commercial and hospitality seating, healthcare facilities and athletic equipment. UNIR’s main brands names include Naugahyde®, BeautyGard®, Flameblocker™, Spirit Millennium®, Ambla®, Amblon®, Velbex®, Cirroflex®, Plastolene® and Vynide®.

UNIR’s products for the automotive industry are chiefly used in seating, door panels, head and arm rests, security shades and trim components, including instrument panels, door casings, seating, gear lever and steering column gaiters, headliners and load space covers. Moreover, non-automotive applications include outdoor seating for utility and sports vehicles, and sheeting used in medical, nuclear protection, personal protection, moisture barriers, pram and nursery, movie screen and decorative surface applications.

In 2018, UNIR’s revenue was derived 66.2 percent from the automotive industry. Roughly 33.8 percent was derived from the recreational, industrial, indoor and outdoor furnishings, hospitality and healthcare markets.

UNIR has opened a new Detroit, Michigan area office dedicated to the North American automotive market. This new office features a design studio along with a sales team committed to serving existing original equipment manufacturer (OEM) customers and new automotive clients. The office is in Farmington Hills. It joins other UNIR offices in Stoughton, Wisconsin; Sarasota, Florida; Earby, Lancashire, UK; and Shanghai, China.

Recently, UNIR reported its financial results for the three months ended March 31, 2019. Net Sales for the three months ended March 31, 2019 decreased $1,035,827 or 3.9 percent to $25,393,860 from $26,429,687 recorded in the year prior. Excluding the negative currency effect of the exchange rates, Total Revenue would have only decreased by about $33,000 or 0.1 percent.

Operating Income for the three months ended March 31, 2019 was $880,397, in comparison to $898,200 in the prior year. This represents a decline of $17,803 or 2.0 percent. The main reasons for the drop were lower sales and a contraction in Gross Profit margins to 17.0 percent this year in comparison to 17.5 percent in the prior year.

Uniroyal Global Engineered Products, Inc. (UNIR), closed Thursday's trading session at $1.20, up 15.3846%, on 250 volume with 2 trades. The average volume for the last 3 months is 630 and the stock's 52-week low/high is $1.00/$1.75.

chart

Kutcho Copper Corp. (KCCFF)

InvestorX, Junior Stock Review, Investors Hangout, The Prospector News, Mining & Energy, Wallet Investor, OTC Markets, Resource Stock Digest, Market Screener, 4-Traders, Stateside Report, Junior Mining Network, Stock Orange, Resource World, Dividend Investor, Stockhouse, Barchart, Stockwatch, and MarketWatch reported previously on Kutcho Copper Corp. (KCCFF), and today we choose to highlight the Company, here at the QualityStocks Daily Newsletter.

Kutcho Copper Corp. concentrates on expanding and developing the Kutcho high grade copper-zinc project in northern British Columbia. The Company’s intention is to progress the Kutcho Project through feasibility and permitting to a positive construction decision. A resource development company, Kutcho Copper is headquartered in Vancouver, British Columbia (B.C.).

The Kutcho Copper Project is Kutcho’s 100 percent owned high grade copper-zinc development project in northern B.C. This Project is in a top tier mining jurisdiction with major mines and permitted projects in Tahltan and Kaska territories. Kutcho Copper has a Probable Reserve of 10.4 Mt grading 2.01% Cu and 3.19% Zn (2.92% CuEq).

The Kutcho Copper Project has a Mine Life of 12 years. Its Production Rate is 2,500 tpd. The Project has low risk potential to increase Mineral Reserves and substantially increase production capacity.

The Wheaton Precious Metals stream establishes a basis for a strong partnership and lessens financial risk of the Project. Furthermore, there is the potential for more discoveries via exploration. Kutcho Copper’s objective is to increase reserves from the present 10.4 Mt through existing resource conversion.

Kutcho Copper has launched MineHub Technologies, Inc. with a syndicate of industry partners. This includes a senior mining company, one of the world’s largest streaming companies, a global base and precious metals and concentrates trading company and an international financial institution providing banking services in the metals and mining industry. MineHub is a leading-edge technology company taking advantage of blockchain technology to develop a new generation of applications for the metals and mining industry.

Recently, MineHub Technologies and IBM announced a collaboration to use blockchain technology to help improve operational efficiencies, logistics and financing and decrease costs in the high-value mineral concentrates supply chain - from mine to end buyer. Kutcho Copper, Goldcorp, Inc., ING Bank, Ocean Partners USA, Inc. and Wheaton Precious Metals are working with mining technology company MineHub to build the new mining supply chain solution on top of the IBM Blockchain Platform.

In addition, Kutcho Copper also recently announced it appointed Mr. Michael Rapsch as Vice President of Corporate Communications. Mr. Rapsch has a decade of in-depth investor relations and corporate communications experience. Before joining Kutcho Copper he held the position of Vice President, Corporate Communications at SilverCrest Metals, Inc. for the last three years.

Kutcho Copper Corp. (KCCFF), closed Thursday's trading session at $0.132, up 18.9189%, on 3,225 volume with 3 trades. The average volume for the last 3 months is 10,121 and the stock's 52-week low/high is $0.096600003/$0.349900007.

chart

MOJO Organics, Inc. (MOJO)

Investor Place, Barchart, InvestorsHub, Market Screener, Equity Clock, Wallet Investor, 4-Traders, Penny Stock Tweets, Vending Market Watch, The Street, TradingView, Insider Financial, Stockopedia, Capital Cube, Business Insider, and Simply Wall St reported earlier on MOJO Organics, Inc. (MOJO), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

MOJO Organics, Inc. engages in product development, production, marketing, and the distribution of beverages. The Company’s beverages are Non-GMO (Non-Genetically Modified) Project Verified. Its products include coconut water, sparkling coconut water, as well as tropical juice. Incorporated in 2007, MOJO Organics is based in Jersey City, New Jersey.

MOJO beverages have zero added sugar, no preservatives and low sodium. Additionally, MOJO is vegan and gluten free. The Company’s tropical juice comes in three flavors. These are mangosteen juice, dragon fruit juice, and pomel juice.

MOJO coconut water comes in four flavors. These are regular coconut water, pineapple juice, passion fruit juice, and mango juice. The Company’s sparkling coconut water comes in the same four flavors. MOJO Pure Coconut Water has been ranked in the top five brands of coconut water on Amazon.

Recently, MOJO Organics reported its results of operations for the quarter ended December 31, 2018. Financial highlights include Net Revenue increasing to $405,741. This represents a 40 percent increase from the same quarter last year.

Operating Margin increased to 50 percent from 43 percent for the same quarter last year. Net Loss decreased to $145,315 from $188,311. This represents a 23 percent improvement from the same quarter last year.

MOJO Pure Coconut Water + mango juice is expected to launch on Amazon this month. In addition, this month, MOJO Organics plans to launch its new product website highlighting new products and the Company’s refreshed branding.

Mr. Glenn Simpson, Chairman and Chief Executive Officer of MOJO Organics, Inc. said, "We are pleased to report that we ended our 2018 fourth quarter within our expectations. We hit many milestones including strong growth in revenue and operating margin during the quarter…During the fourth quarter, we increased unit cases sales to 36,600 from 27,400 for the same quarter last year. This was the fifth consecutive quarter of double digit revenue growth and unit case growth.”

MOJO Organics, Inc. (MOJO), closed Thursday's trading session at $0.19, up 25.8278%, on 100 volume with 1 trade. The average volume for the last 3 months is 2,096 and the stock's 52-week low/high is $0.0251/$0.449999988.

chart

CurAegis Technologies, Inc. (CRGS)

Penny Stock Tweets, Dividend Investor, Insider Mole, Equity Clock, Market Screener, Morningstar, MarketWatch, 4-Traders, InvestorsHub, Stockwatch, Investor Place, Simply Wall St, Marketbeat, Capital Cube, YCharts, Stock Invest, Barchart, The Street, OTC Markets, Infront Analytics, Stockhouse, last10k, Wallet Investor, and TradingView reported earlier on CurAegis Technologies, Inc. (CRGS), and today we choose to report on the Company, here at the QualityStocks Daily Newsletter. 

CurAegis Technologies, Inc. develops and markets advanced technologies in the areas of power, safety, and wellness. The Company consists of two independent divisions. One is its CURA Division and the other is its Aegis Division.  CurAegis is now concentrating on commercialization strategies in diverse technologies. These include the CURA system, which includes the myCadian™ watch that measures degradation of alertness and sleep attributes; the Z-Coach e-learning education and training tool, and the Aegis hydraulic pump. OTCQB-listed, CurAegis Technologies is based in Rochester, New York.

The CURA™ system and the myCadian™ watch enable the user and third parties to anticipate and prevent undesired or disastrous situations caused by the degradation of alertness. CurAegis completed its validation studies of the CURA System at the University of Colorado at Boulder and the University of Rochester Medical Center. The Company previously said that it can now state that it can predict a person’s fatigue level, at close to laboratory accuracy, in real-time.

The CURA System consists of hardware and software, which measures numerous metrics to establish that a person's ability to perform a task or job appears to be degrading. The CURA division is developing a proprietary technology and family of products designed to measure the reduction in a person’s alertness and to train persons on how to improve alertness levels. The CURA System gives a person accurate and relevant real-time information regarding their current and long-term sleep and fatigue health.

The Company’s Aegis hydraulic pump (Aegis Division) is an innovative hydraulic design. Its goal is to deliver better efficiencies in a package that is smaller and lighter than contemporary technologies.  Moreover, in 2015, the Z-Coach e-learning tool was acquired by CurAegis Technologies. The Z-Coach® Wellness Program is a robust, proven and proprietary online sleep training and education solution to address sleep issues and improve wellness.

Recently, Mr. Richard A. Kaplan, Chief Executive Officer of CurAegis Technologies announced that Mr. Lance F. Drummond was appointed to the Company’s Board of Directors. At present, Mr. Drummond is a Board member of Federal Home Loan Mortgage Corporation (Freddie Mac). He has served on the Audit Committee and Nominations and Governance Committee since 2015. He is a Board member for United Community Bank, Inc. since 2018, where he serves on the Risk Committee, Nominating and Governance Committee and Compensation Committee.

CurAegis Technologies, Inc. (CRGS), closed Thursday's trading session at $0.095, off by 5.00%, on 23,000 volume with 4 trades. The average volume for the last 3 months is 11,112 and the stock's 52-week low/high is $0.050500001/$0.419999986.

chart

MoneyOnMobile, Inc. (MOMT)

Stockflare, Marketwired, Stockopedia, Barchart, The Street, TradingView, YCharts, 4-Traders, OTC Markets, MarketWatch, InvestorsHub, and Morningstar reported on MoneyOnMobile, Inc. (MOMT), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

OTCQB-listed, MoneyOnMobile, Inc. is one of India's largest mobile phone-based payment networks. The Company facilitates easy, safe, and secure financial transactions to millions of Indians. Its core belief is in providing service to the unbanked consumer, by way of Financial Inclusion and self-dependence.

The Company previously went by the name Calpian, Inc. It changed its corporate name to MoneyOnMobile, Inc. in August 2016. Incorporated in 2006, MoneyOnMobile has offices in Dallas, Texas, and Mumbai, India.

The Company’s services include money transfer, mobile recharge, bill payment, DTH recharge, train tickets, flight tickets, hotel booking, and online shopping. It designed MoneyOnMobile to work across all mobile phone handsets. This is from the most basic to the most advanced.

MoneyOnMobile continually innovates to provide a range of innovative solutions together with its continuous, premier, 24 x 7 transactional convenience via a simple SMS, Application and Web Portal.

MoneyOnMobile has authorization by the Reserve Bank of India (RBI) to set up a semi-closed payment system in India. This system enables registered users to buy goods, products, and services from registered Merchants.  MoneyOnMobile provides a broad array of services on a real-time basis, irrespective of geography, time, and mobile operator.

MoneyOnMobile announced in June the launch of the Reserve Bank of India's payment service (Bharat Billpay) through the MoneyOnMobile retailer platform. The launch of the new service enables its retailers to meet the growing demand for digital payment services among the estimated 600-800 million unbanked/underbanked population of India and increase the monthly spend of its existing customers.

Recently, MoneyOnMobile announced the number of MOM ATM units deployed in India has surpassed the 10,000-unit mark. Mr. Harold Montgomery, MoneyOnMobile’s Chairman and Chief Executive Officer, said, "We are pleased with the progress of our MOM ATM deployments. Crossing the 10,000-unit mark demonstrates, we believe, strong demand for this product by our retailers. We are well on our way to reaching our goal of 30,000 MOM ATM units deployed by the end of 2019. This is the first step in the cycle of deployment activation and revenues.”

MoneyOnMobile, Inc. (MOMT), closed Thursday's trading session at $0.055648, up 261.3506%, on 200 volume with 2 trades. The average volume for the last 3 months is 818 and the stock's 52-week low/high is $0.014999999/$0.839999973.

chart

Accelerize, Inc. (ACLZ)

Buzz Stocks, Greenbackers, ResearchOTC, StockRockandRoll, Planet Penny Stocks, PennyStockProphet, StockOnion, FeedBlitz, Penny Pick Finders, StockOodles, and PennyStockLocks reported previously on Accelerize, Inc. (ACLZ), and today we are reporting on the Company, here at the QualityStocks Daily Newsletter. 

Accelerize, Inc. provides marketing technology solutions that transform the way advertisers leverage their digital advertising data. CAKE is a division of Accelerize and is the Company’s digital marketing software division. CAKE provides a cloud-based solution to track and analyze the performance of digital marketing Return on Investment (ROI), in real-time. Accelerize has its corporate headquarters in Newport Beach, California.

CAKE is a software-as-a-service (SaaS) enterprise platform. It provides online tracking, reporting, lead distribution, and analytics solutions for advertisers, online marketers, affiliate marketers, and lead generators. With CAKE, one can track and optimize affiliate traffic. In addition, a user can collect, validate and distribute leads. Furthermore, one can gather and analyze multi-channel data. 

Accelerize offers CAKE for Advertisers and CAKE for Networks. CAKE for Advertisers is a SaaS solution. It enables brand advertisers to unify the tracking, attribution, and optimization of digital marketing spend across search, display, email, video, social, affiliate, and other marketing channels.

CAKE for Networks is a marketing solution for affiliate networks. CAKE by Accelerize is headquartered in Newport Beach, with operations in New York, London, India, and Sydney, Australia.

Constructed on CAKE’s Marketing Intelligence platform, Journey is a cloud-based enterprise solution. Journey collects and analyzes customer journey data using multi-touch attribution for marketing campaign optimization.

Recently, Accelerize and its digital marketing software division CAKE announced major momentum in the Asia-Pacific (APAC) region. Revenue and Customer Growth increased by triple digit percentages over a two-year period.

Since establishing itself in important APAC markets in 2015, including India, China, Singapore, Indonesia, Australia and more, CAKE’s revenues in the region have increased by 322 percent, with a 283 percent increase in the number of APAC clients.

Santi Pierini, CAKE President and Chief Operating Officer of Accelerize, said, “International markets represented about 40 percent of our sales overall in 2017, and APAC continues to play an important role in CAKE’s ongoing growth strategy.”

Accelerize and CAKE also recently announced its growing ecosystem of Connections, alliances with top digital media and marketing tools, which enrich customer journey insights for brands, agencies and publishers. Available to Journey by CAKE users, Connections enable digital marketers to easily extract data from media platforms. With this data, they can rapidly integrate it into a single platform - CAKE’s enterprise SaaS solution.

Accelerize, Inc. (ACLZ), closed Thursday's trading session at $0.0375, up 88.4422%, on 1,155,328 volume with 47 trades. The average volume for the last 3 months is 58,527 and the stock's 52-week low/high is $0.018999999/$0.219999998.

chart

RepliCel Life Sciences, Inc. (REPCF)

OTCPicks, Greenbackers, Investor Spec Sheet, StockGuru, TheStockAdvisor, 24-7 Stock Alert, Beacon Equity Research, Crazy Carl, Global Equity Report, The Green Baron, Club Penny Stocks Network, Streetwise Reports, InvestorSoup, Penny Stock Explosion, SmallCapReview, Stock Preacher, Penny Stocks Finder, ShazamStocks, and StockHideout reported earlier on RepliCel Life Sciences, Inc. (REPCF), and today we report on the Company, here at the QualityStocks Daily Newsletter.

RepliCel Life Sciences, Inc. is a regenerative medicine company listed on the OTC Markets’ OTCQB. The Company concentrates on the development of cell therapies for aesthetic and orthopedic conditions. These include aging/sun-damaged skin, pattern baldness, and chronic tendon degeneration. All of its product candidates are based upon RepliCel’s unique technology using cell populations isolated from a patient's healthy hair follicles. RepliCel Life Sciences has its headquarters in Vancouver, British Columbia.

The Company’s product pipeline consists of RCT-01 for tendon repair, RCS-01 for skin rejuvenation, as well as RCH-01 for hair restoration. Currently, RCH-01 is being co-developed with, and under exclusive license by, Shiseido for certain Asian countries. In addition, RepliCel has developed a proprietary injection device RCI-02, optimized for the administration of its products and licensable for use with other dermatology applications.

RepliCel Life Sciences is investing in research that the Company states has the potential to lead to a number of future products. These include other chronic tendinopathies (patellar tendinosis, tennis elbow, golfer’s elbow, rotator cuff); other dermatologic indications (acne scaring, etc.); gingivitis, and allogeneic versions of the Company’s proven autologous cell therapies.

In September 2017, RepliCel Life Sciences announced the timely arrival of its functioning RCI-02 prototypes. These became ready to be showcased to potential end users and licensing partners.

With these prototypes in-hand, the Company is engaging with important opinion leaders and clinical dermatologists to ask for feedback vitally important to aligning successful early adoption of the device, design clinical studies demonstrating its advantages in select applications, and position RepliCel for an anticipated successful launch of an approved next-generation dermal injector in the European market this year.

Recently, RepliCel Life Sciences announced that it signed a Binding Term Sheet with YOFOTO (China) Health Industry Co. Ltd. (YOFOTO) to establish a strategic partnership in Greater China (Mainland China, Hong Kong, Macau, and Taiwan). The deal involves an up-front investment of USD $6,500,000 and potential pre-commercial, non-dilutive milestones payments of another USD $2,800,000.

Moreover, the Term Sheet commits YOFOTO to another USD $1,000,000 in potential post-commercial non-dilutive milestone payments, several million in dedicated program funding in Greater China over the next five years, and future royalty payments calculated on gross product sales in the Territory.

RepliCel Life Sciences, Inc. (REPCF), closed Thursday's trading session at $0.218255, up 28.3853%, on 1,110 volume with 3 trades. The average volume for the last 3 months is 6,253 and the stock's 52-week low/high is $0.167999997/$0.363700002.

chart

The QualityStocks Company Corner

Organigram Holdings Inc. (TSX: OGI) (NASDAQ: OGI)

The QualityStocks Daily Newsletter would like to spotlight Organigram Holdings Inc. (OGI).

Organigram Holdings Inc. (TSX: OGI) (NASDAQ: OGI) was highlighted today in a publication from Motley Fool, examining how Canada lifted the curtain on nine decades of recreational cannabis prohibition and allowed for the legal sales of adult-use marijuana one year ago. Today, on Oct. 17, 2019, our neighbor to the north will move forward with the next phase of the marijuana legalization process, affably known as "legalization 2.0."

Organigram Holdings Inc. (TSX: OGI) (NASDAQ: OGI) is the parent company of Organigram Inc., a leading Canadian licensed producer (“LP”) of high-quality cannabis and extract-based products. Founded in 2013, Organigram is focused on producing high quality, indoor-grown cannabis for patients and adult recreational consumers in Canada, as well as developing international business partnerships to expand the Company’s global footprint. 

The Company has distribution arrangements in all 10 provinces1. Organigram delivers industry-leading yields and maximizes quality cannabis production at the lowest cultivation cost per gram among publicly reporting Canadian LPs.

Financial Results

In Q2 2019, the Company reported record net revenue of C$26.9 million, cash cost of cultivation of C$0.65 per gram, industry leading gross margin of C$16 million or 60% and adjusted EBITDA of C$13.3 million or margin of 49%, positive for the third consecutive quarter.

Significant Expansion Plans with Streamlined Licensing Process

Located in Moncton, New Brunswick, Organigram’s production facility and research & development program includes a state of the art, indoor 3-tier cultivation system which maximizes facility square footage. Its Phase 4 expansion project is expected to be completed by the end of 2019 for increased target production capacity of 113,000 kg/year (249,000 lbs)2. As the Company expands its cultivation and processing capacities, Organigram is able to file amendments to the existing facility and each new production area is largely a replica of previously licensed areas, which results in a relatively streamlined and predictable licensing process with Health Canada.

In addition to increased production capacity from Phase 4, Organigram’s Phase 5 expansion includes plans for additional extraction capacity and its own edibles facility. Construction is expected to be substantially completed in October 2019.

Proprietary Technology

The Company’s indoor facility allows for control of all critical facets of the lighting and environmental elements to drive maximum quality and yield in the plants. The Company’s in-house proprietary information technology system, called OrganiGrow, tracks grow cycles, environmental conditions and other factors to optimize cultivation.

Numerous design and automation improvements include automated potting, pre-roll and packaging machines, and larger propagation rooms with advanced environmental systems.

Well Positioned for Canada’s Legalization of Edibles and Other Derivatives Products

Through its facility expansions, partnerships and research and development, the Company is well-positioned to capture further growth from the legalization of edibles and derivative products expected in October 2019. Its initial product focus is on vaporizable products and edibles.

Organigram’s development of a shelf-stable, thermally stable, water-soluble and tasteless cannabinoid nano-emulsion formulation may provide for an initial onset of effect within 10 to 15 minutes in a beverage. Non-cannabis formulations with a similar molecule size are water-soluble in humans (i.e., absorbed through the bloodstream rather than requiring first-pass liver metabolism, which results in longer onset and duration uncertainty). The Company expects to receive research and development licensing in the near term, at which point testing will be conducted to confirm the onset and duration.

Organigram has entered into an exclusive consulting agreement with The Green Solution (TGS), a proven market leader based in Denver, Colorado for the development of commercial scale extraction and derivative product development in Canada. Organigram’s partnership with Canada’s Smartest Kitchen, a leader in food product development, will expand the Company’s edibles R&D program.

The Company recently announced a C$15 million investment commitment in a high-speed, high-capacity, fully automated production line with a capacity of 4 million kilograms of exceptional chocolate cannabis edibles per year.

Organigram also has a multiyear extraction contract with Valens GroWorks Corp. to produce extract concentrate for oils and other derivative products.

Disruptive Technology

Through its partnership with Hyasynth Biologicals Inc., a biotech company and leader in the field of cannabinoid science and biosynthesis, Organigram has invested in a potentially disruptive technology that uses patented yeast strains and enzymes to naturally produce cannabinoids without growing the cannabis plant. This process has the potential to create a global supply of pure cannabinoids at a fraction of the cost of traditional cultivation. Organigram views this investment as providing early access to what it expects to be the future of cannabinoid production – cost-effectiveness, purity and scalability.

International

Organigram believes there will be increasing demand for CBD in Canada and beyond. As such, the Company has invested in Alpha-Cannabis Germany (ACG) and expects to provide ACG with flower for conversion into extracts. ACG is a medical cannabis provider serving the largest legalized medical market in Europe. The Company anticipates entering into an agreement with ACB to purchase pure synthetic CBD isolate in the future.

Organigram is also invested in Eviana Health Corp. (CSE: EHC), a Serbian-based company with hemp farming and processing assets.

Experienced Executive Team

  • CEO Gregory Engel has 30 years of national and international experience in pharmaceuticals, biotechnology, cannabis, and consumer packaged goods (CPG), and most recently served as CEO of Tilray Inc. where he was instrumental in the company becoming the first Canadian exporter of medical cannabis, as well as establishing several trailblazing industry standards
  • Jeff Purcell, Senior Vice President of operations, has 25 years of experience in operations for companies such as Ganong Chocolates and McCain Foods
  • Tim Emberg, Senior Vice President of Sales and Commercial operations, has 20 years of experience in pharmaceutical sales and marketing in the OTC and CPG industries
  • Paolo DeLuca, Chief Financial Officer, has 20 years of diversified financial business experience including with West Face Capital and TD Securities
  • Ray Gracewood, Senior Vice President, Marketing & Communications, has 15 years of experience in the marketing space and was senior Director of Dales and Marketing for Moosehead Breweries Ltd.

This profile contains certain non-IFRS performance measures including cash and all-in cost of cultivation per gram, net revenue, adjusted EBITDA, and adjusted gross margin which are not calculated in accordance with IFRS and may not be comparable to similar data presented by other companies. Please see the company’s Q2 2019 MD&A.

1 Subject to final regulatory approval from Quebec
2 Several factors can cause actual capacity and costs to differ from estimates. See “Risks and Uncertainties” in the Company’s Q2 2019 MD&A and “Risk Factors” in the latest Annual Information Form.

Organigram Holdings Inc. (NASDAQ: OGI), closed Thursday's trading session at $3.73, up 8.4302%, on 1,907,946 volume with 6,121 trades. The average volume for the last 3 months is 1,268,986 and the stock's 52-week low/high is $2.71000003/$8.43999958.

Recent News

chart

The Green Organic Dutchman (TSX: TGOD) (OTC: TGODF)

The QualityStocks Daily Newsletter would like to spotlight The Green Organic Dutchman (OTC: TGODF).

The Green Organic Dutchman (TSX: TGOD) (OTC: TGODF) was featured today in the 420 with CNW by CannabisNewsWire. On Monday, Scott Gottlieb, the former Food and Drug Administration Commissioner, said that the federal government should be given the authority to regulate states’ marijuana programs.

The Green Organic Dutchman (TSX: TGOD) (OTC: TGODF), whose principal location is in Hamilton, Ontario, produces farm grown, organic, pesticide-free medical cannabis in small batches using all natural, organic craft growing principles. TGOD is licensed under the Access to Cannabis for Medical Purposes Regulations (ACMPR) to cultivate medical cannabis. The company carries out its principal activities producing cannabis pursuant to the provisions of the ACMPR and the Controlled Drugs and Substances Act (Canada).

Committed to becoming the global leader in delivering organic cannabis solutions that enhance people’s lives, TGOD consistently adheres to the highest levels of excellence. Its world-class management team includes a proven group of leaders with outstanding executive and operational experience specific to consumer packaged goods, consumer products, cannabis and finance industries.

TGOD is positioned as one of the highest quality and most cost efficient cannabis producers in Canada by leveraging innovative technology and low-cost power solutions. It holds one of the largest land packages under a single ACMPR license in Canada, providing future cannabis Agri-park style development and opportunities for joint ventures, licensing and distribution partners. Its industry leading alliance partners include Eaton, Ledcor Group and Hamilton Utilities Corp.

Eaton is the second largest power management company in the world and promises to supply innovative and cost effective power solutions to meet TGOD’s growing demands. Construction management is supplied by Ledcor, Canada’s second largest multidisciplinary construction company and a pioneer in the Green Building Industry. An alliance with Hamilton Utilities Corp allows TGOD to reduce its power costs from $0.13 per kWh to less than $0.05 per kWh. Greenhouse design is provided by Larssen Greenhouse, whose 25-plus years of experience in building some of the most modern and sophisticated greenhouses in the industry will provide TGOD with state of the art, climate-controlled hybrid greenhouse solutions.

Canada is quickly becoming a hub for cannabis investors with over $1.3 billion raised by Canadian companies to date. There are 58 licensed producers to service a population of 36 million and only two organic producers. TGOD, which holds licenses in Ontario and Quebec, is strategically located in both provinces that together claim 22 million Canadians as residents. Another estimated 57 million people live next door in six U.S. bordering states.

The Canadian cannabis market currently has a massive supply demand gap, which makes TGOD’s expansion plans even more important to investors. These plans include a combined build-out capacity of 970,000 square feet, allowing TGOD to produce 116,000 kg annually of organic cannabis. Upon completion, Phase One in Hamilton, Ontario, which is fully funded, will provide 150,000 square feet of growing capacity capable of producing up to 14,000 kg of cannabis or $112 million in revenue at $8 a gram.

The company’s Quebec expansion will be constructed on a recently secured 75-acre property near Montreal. This new property has a planned expansion of 820,000 square feet capable of producing 102,000 kg of organic cannabis. The first phase of this expansion is underway and construction is expected to be completed by the end of 2018. Quebec’s first phase will consist of 220,000 square feet capable of producing 22,000 kg of cannabis. Two additional expansion phases will add 250,000 square feet (26,000 kg of cannabis) and 350,000 square feet (54,000 kg of cannabis). Power costs remain exceptionally low for both facilities with access to all other needed utilities available and close by.

TGOD also plans to gain a share of the burgeoning cannabis oils market which by Q1 2017 accounted for 49 percent of all cannabis sold in Canada under the ACMPR, up from only 27% in Q2 2016. TGOD has ordered a purpose-built extraction laboratory with an estimated commission in Q4 of 2017. This is a commercial-scale CO2 extraction unit capable of processing up to 12,000 kg of raw material per year and producing approximately $170 million worth of organic cannabis oils. Raw cannabis oil provides a significant downstream manufacturing opportunity into several potential recreational market verticals including edibles, beverages, topicals and concentrates.

Data from the Canadian ACMPR Market Trends report indicates a rising number of consumers will continue to seek out healthier, less conspicuous ways to consume cannabis, ensuring sales of organic cannabis oil products remain brisk. Organic cannabis products demand a significant premium compared to non-organic products and the demand keeps growing.

Plans to take the company public are underway with an initial public offering (IPO) slated for January 2018. In November, the company raised $13 million in equity financing and in March closed a $27 million non-brokered private placement. Another $20 million is currently being raised before the IPO in January, which will be utilized for expansion plans.

TGOD is uniquely positioned between the medical and recreational cannabis industry since Canada is scheduled to legalize cannabis for all adults in mid-2018. As of August 2017, TGOD has 2,400 shareholders. Established in 2012, TGOD’s motto, “Making Life Better,” can be seen in its strategic partnerships, top quality management team, and dedication to organic farming and principles.

To learn more about the company and how to invest, contact TGOD directly at financing@tgod.ca

The Green Organic Dutchman (OTC: TGODF), closed Thursday's trading session at $1.06, up 10.4167%, on 975,271 volume with 706 trades. The average volume for the last 3 months is 921,680 and the stock's 52-week low/high is $0.819000005/$4.4499998.

Recent News

chart

The Supreme Cannabis Company Inc. (TSX.V: FIRE) (OTC: SPRWF)

The QualityStocks Daily Newsletter would like to spotlight Supreme Cannabis Company Inc. (OTC: SPRWF).

The Supreme Cannabis Company, Inc., (TSX: FIRE) (OTCQX: SPRWF) (FRA: 53S1) Chief Advocacy Officer, John Fowler has launched a cannabis focused podcast called Session Garden. Session Garden with John Fowler is a rare backstage pass to the way the biggest names in the cannabis community are thinking about the hottest topics in the industry. Also today, the company was featured in a publication from CBDWire, examining how CBD has built quite a reputation in the few years it has been mainstream. The list of diseases CBD has in the past proven effective against spans from minor conditions such as anxiety and inflammation to severe ones like chronic pain and epilepsy. At this point, it’s anyone’s guess what else cannabidiol works against.

Supreme Cannabis Company Inc. (TSX.V: FIRE) (OTC: SPRWF), is committed to providing premium brands and products that reflect the company’s knowledgeable customers, passionate employees, and culture of innovation. Supreme Cannabis’ mission is to grow the world’s best cannabis and become a leader in the global industry. The company calls its Toronto Venture Exchange stock symbol FIRE “a testament to our passion for cannabis and our obsession with quality.”

Supreme Cannabis believes the world is ready to follow Canada’s lead by ending the 100-year cannabis prohibition and, as Canada’s only coast-to-coast premium cannabis producer, the company sees itself at the center of this global shift.

In August 2018, Supreme Cannabis uplisted its shares to the to OTCQX market in the U.S., where the company trades under the ticker symbol SPRWF. The following month Supreme reported record Q4 revenues of CAD$3.55 million, a 71-percent increase over the previous quarter. Supreme Cannabis also recorded revenue of CAD$8.85 million for its fiscal year ended June 30, 2018, placing it among publicly traded Canadian cannabis companies with the highest reported revenue in their first four quarters of sales.

“As a result of the successful execution of our strategy, we have generated significant revenue growth both for the quarter and the year-end period,” Supreme Cannabis CEO Navdeep Dhaliwal stated in a news release. “We look forward to building on this growth as we expand domestically and internationally.”

The company’s growth strategy includes key industry agreements, such as its CAD$12 million supply agreement with Tilray Inc. (OTC: TLRY), a global leader in cannabis research, cultivation, processing and distribution. The agreement calls for Supreme to supply Tilray with dried cannabis for support of medical cannabis patients in Canada for the period of one year.

Another key component is the company’s wholly owned 7ACRES subsidiary. The 7ACRES cultivation facility, one of the first 40 federally licensed cannabis producers in Canada, is focused on building a core competency in scaled cannabis production, which will give 7ACRES the needed flexibility to maintain leadership in the industry as the Canadian market grows and matures. Though 7ACRES is Supreme Cannabis’ flagship brand and only currently operating business unit, the company will continue to identify new opportunities to grow its portfolio of companies and build innovative cannabis businesses throughout the world.

7ACRES operates from a 342,000-square-foot cultivation facility in Kincardine, Ontario, and has been federally licensed since 2016. Current capacity is 13,333 kilograms dried cannabis annually, with plans to ramp up production by mid-2019 to a rate of 50,000 kilograms per year.

Supreme Cannabis seeks to differentiate 7ACRES from other licensed cannabis producers by producing premium quality product sustainably at scale. “Craft quality, commercial scale” is a slogan the company uses, and the Kincardine greenhouse employs state-of-the-art technology and cultivation best practices to strive toward that goal. Supreme identifies the quality of the 7ACRES product as the company’s primary strength and says a shared “passion for the plant” is the driver of company culture. Six Canadian provinces have signed supply agreements with Supreme, a fact the company credits to the high quality of 7ACRES cannabis.

Its customers, Supreme Cannabis management says, are informed and discerning regarding cannabis, and they value a premium brand that respects their product knowledge. The company believes its high regard for customers, premium product quality, and mass cultivation capability has allowed Supreme Cannabis to emerge as Canada’s preeminent premium cannabis producer. In the Canadian cannabis market, the company has established 7ACRES as a premium brand that’s distributed coast-to-coast and commands premium pricing. The 7ACRES brand is already listed as premium cannabis product in all provinces that disclose their cannabis listing categories, and 7ACRES on average wholesales for up to one-third higher in price than other brands in the Canadian cannabis market.

To further its distribution, in the medical cannabis market Supreme Cannabis has partnered with several Canadian cannabis retailers including Aurora Cannabis, Emerald Health Botanicals, Namaste, Zenabis, and others. The company’s investment portfolio also includes an equity position and long-term global distribution partnership with Medigrow, based in Lesotho, targeting the export of medical cannabis oil for the international market.

Supreme Cannabis seeks to make the company an innovator in the cannabis sector regarding design of cultivation facilities and development of operation excellence metrics. The management team is confident that the 7ACRES flagship brand, the company’s proprietary technology and products, and the company’s culture of passion for cannabis will deliver consistent long-term shareholder value.

Supreme Cannabis Company Inc. (OTC: SPRWF), closed Thursday's trading session at $0.70, up 0.143062%, on 567,871 volume with 426 trades. The average volume for the last 3 months is 483,066 and the stock's 52-week low/high is $0.636600017/$1.7888.

Recent News

chart

Petroteq Energy Inc. (TSX.V: PQE) (OTCQX: PQEFF)

The QualityStocks Daily Newsletter would like to spotlight Petroteq Energy Inc. (PQEFF).

Petroteq Energy (TSX.V: PQE) (OTC: PQEFF), a fully integrated, surface oil-sands, clean-recovery mining oil company with proprietary technology, recently resumed production at its eastern Utah Asphalt Ridge facility following upgrades to improve its equipment’s ability to separate coarse sands and extract fluids, and then return the cleaned sands to the ground. To view the full article, visit http://nnw.fm/sn5Y3.

Petroteq Energy Inc. (TSX.V: PQE) (OTCQX: PQEFF) is a Canadian-registered, publicly traded company engaged in the development and implementation of proprietary technologies for the environmentally safe extraction of heavy oils from oil sands, oil shale deposits and shallow oil deposits. The company is focused on oil sands exploration and production on mineral leases in Vernal, Utah, and in expanding production capacity at its Asphalt Ridge heavy oil extraction facility in Utah.

Petroteq Energy’s patent-pending application is a closed-loop, solvent-based process, which results in significantly lower per-barrel production costs than those incurred with traditional hot water-based oil sands extraction technologies. This green technology utilizes a small, modular footprint, produces no greenhouse gases, requires no high temperatures, leaves only clean dry sand, and could be deployed to unlock heavy oil deposits located around the world.

The Company’s Asphalt Ridge mineral lease on 2,500-plus acres in northeastern Utah features a large contingent oil sands resource base with an estimated 87 million barrels of oil equivalent. In 2015, the company produced 10,000 barrels of oil from the Utah location and plans to increase production are underway. Utah holds over 32 billion barrels of undeveloped oil sands resources, which are also known as “oil-wet” deposits containing a mixture of sand and a dense, extremely viscous form of petroleum referred to as bitumen or tar. A recent upswing in developing domestic energy sources has intensified interest in technological advances such as Petroteq’s Clean Oil Recovery Technology (CORT) System.

The Company continues to evaluate the development of other medium to heavy oil exploration, production and recovery projects on a global basis through a variety of structured agreements. These opportunities or other arrangements with private and governmental entities that utilize Petroteq Energy’s proprietary licensed technologies are expected to generate a significant return on investment.

The Company’s management team, board of directors and officers form an invaluable cross-section of industry leaders with extensive experience ranging from chemical engineering and solvent research, business development, international project management, entrepreneurial achievements, and senior management for global energy companies in North America and the Middle East. This impressive knowledge base covers both conventional and unconventional oil and gas projects and production, both in upstream and downstream industry sectors.

Petroteq Energy is also participating in a blockchain initiative aimed at solving the global transaction needs of the oil and gas industry through the development of PetroBLOQ. PetroBLOQ recently joined the Enterprise Ethereum Alliance (“EEA”), the world’s largest open-source blockchain initiative. Membership with the 200-member EEA represents a wide variety of industries and offers 14 industry-focused, member-driven working groups.

“Joining this community of forward-looking enterprises and blockchain innovators is an important step for PetroBLOQ as we develop transformative solutions for the oil and gas industry,” said Petroteq Energy Chairman Alex Blyumkin.

In addition, Petroteq has joined the American Petroleum Institute (API). The API is the only national trade association representing all facets of the oil and natural gas industry, promoting safety across the industry globally and influencing public policy in support of a strong, viable oil and natural gas industry.

“API has led the development of operating standards for our industry, and we look forward to contributing our experience with oilfield technologies in addition to introducing our PetroBLOQ platform to its members throughout the supply chain,” Blyumkin previously stated.

Petroteq Energy Inc. (PQEFF), closed Thursday's trading session at $0.1886, up 10.9412%, on 166,982 volume with 38 trades. The average volume for the last 3 months is 229,983 and the stock's 52-week low/high is $0.112099997/$0.819999992.

Recent News

chart

SinglePoint, Inc. (SING)

The QualityStocks Daily Newsletter would like to spotlight SinglePoint, Inc. (SING).

Based in Phoenix, Arizona, SinglePoint Inc. (OTCQB: SING) focuses on diversification into horizontal markets. The Company concentrates on researching opportunities where it can be active within an enterprise by influencing its direction and strategy. Specifically, as of late SinglePoint has shifted its focus to two promising products: its line of Pure American Hemp Cigarettes and its booming solar subsidiary, Direct Solar.

SinglePoint, Inc. (SING) is a diversified holding company with operations in multiple industries and verticals including two high-performing market sectors: legal cannabis and cryptocurrencies. SinglePoint has grown from a full-service mobile technology provider to a recognizable brand with a diverse portfolio of undervalued subsidiaries with multiple revenue streams.

SinglePoint is researching opportunities where it can be an active participant by influencing the strategy and direction of high-potential companies whose verified assets offer attractive possibilities for shareholders. The company is guided by a visionary leadership team with extensive experience in technology, engineering, marketing and raising capital.

SinglePoint is bullish on the cannabis industry, bitcoin and blockchain technologies, which is evident in its recent acquisitions and joint-venture announcements. Recent SinglePoint key highlights include:

  • A joint venture with Smart Cannabis Corporation (OTC: SCNA) to license and market Smart Cannabis’ SMART APP. SMART APP enables cannabis growers to measure all aspects of cultivation, from soil nutrient levels to watering cycles and carbon dioxide content in the air. SMART APP will integrate SinglePoint’s bitcoin payment solution to enable growers to process safer and more secure transactions.
  • A joint venture with Global Payout (OTC: GOHE) will build on existing financial technology solutions developed by SinglePoint and Global Payout’s subsidiary MoneyTrac Technology, Inc., to fully optimize the delivery of mobile payment applications for domestic and international organizations.
  • A joint venture with AppSwarm (OTC: SWRM) to start development on a proprietary delivery application that will enable licensed cannabis delivery services and licensed dispensaries to safely make in-home cannabis deliveries.
  • Signed original “Shark Tank” member Kevin Harrington as company spokesman for an innovative, compatible virtual wallet to store any type of cryptocurrency. Harrington recently finished shooting a new national ad campaign featuring SinglePoint and the virtual wallet’s secure method of storing cryptocurrencies.
  • Entered into a letter of intent to acquire 100 percent of Bitcoin Beyond, a premier platform that enables merchants to accept bitcoin payments using existing web-enabled point-of-sale devices.
  • Through SING subsidiary, SingleSeed, the company will soon offer a proprietary cryptocurrency solution that links both cannabis merchants and consumers who seek to take advantage of bitcoin-powered transactions using debit and credit cards. In addition to making bitcoin-backed card purchases possible, the solution enables cannabis dispensaries to digitally track and manage their product inventories, performing tasks like uploading product data, photos and descriptions. The system deducts items automatically from a dispensary’s product listings when a purchase is made. While this fully KYC-AML compliant point-of-sale platform can be utilized for any other retail setting, it will fill a critical need in the underbanked cannabis industry as it continues to seek non-cash payment solutions outside of traditional banking circles.

SinglePoint CEO and founder Greg Lambrecht leads the company in its mission to capture opportunities through an aggressive expansion strategy across a broad range of assets. Lambrecht oversees all company operations including investor relations, leadership of the board of directors, and daily business activities. As the founder of PCI, a leading consumer product distribution company, Lambrecht negotiated agreements with the nation’s largest retail outlets and led PCI through a NASDAQ listed IPO, raising $10 million.

Eric Lofdahl, SinglePoint’s chief technology officer, has more than 20 years of experience in the technology sector including positions in software development, program management, complex system integration and engineering process definition. Prior to SinglePoint, Lofdahl worked at the Boeing Company where he led a team that successfully developed advanced wireless and satellite data products based on commercial technology for the U.S. Air Force.

SinglePoint President Wil Ralston is well known for his successful track record of building and maintaining great relationships with clients. Ralston graduated cum laude from the WP Carey School of Business at Arizona State University with a degree in Global Agribusiness and a specialization in Professional Golf Management. He is currently recognized by the Professional Golfers Association of America (PGA) as a Class A Professional.

SinglePoint, Inc. (SING), closed Thursday's trading session at $0.0109, up 2.6365%, on 2,170,881 volume with 102 trades. The average volume for the last 3 months is 2,739,216 and the stock's 52-week low/high is $0.009999999/$0.035999998.

Recent News

chart

Neutra Corp. (OTCQB: NTRR)

The QualityStocks Daily Newsletter would like to spotlight Neutra Corp. (NTRR).

Neutra Corp. (OTCQB: NTRR) is an early stage research and development company that was founded in 2015. Neutra Corp. is interested in new technologies, particularly in the nutraceuticals area. It aims to find healthy solutions for living in today’s world. To this end, the company aims to develop and bring to market products that are natural and organically based.

Neutra Corp. (OTCQB: NTRR) is an early-stage research and development company bringing modern healthy living solutions to a multi-billion-dollar market. Cutting-edge technologies within the nutraceuticals, food and drug, and environmental purification sectors are creating a new kind of world culture – one where consumers are demanding access to products that promote health and stave off potential health dangers.

Neutra is concentrating on developing into a vertically integrated company able to cultivate, manufacture and distribute hemp-based cannabidiol (CBD) products. Hemp-based CBD consumer products generated sales of up to $390 million in 2018 with projections pointing to a $3 billion market by 2022, according to the Hemp Business Journal.

Neutra’s new broadened scope, which includes the commercialization of newer, more effective products, aims to capitalize on this worldwide boom. Our company is seeking new and exciting opportunities that can accelerate Neutra’s mission to bring these products to a wider demographic. Our work reflects a renewed dedication to supporting a better body, environment and life for people around the globe.

Acquisitions

  • VIVIS – Neutra continues to expand its market presence in the rapidly growing hemp-derived CBD market and recently acquired VIVIS, an emerging retail brand of hemp-based health and nutritional products. VIVIS’ hemp-derived CBD products are third-party certified as contaminant-free and of consistent quality and potency. Consumers are increasingly looking for this certification when they buy hemp-based CBD products. With VIVIS as the new retail face of Neutra, the company is expecting greater interest in its expanding portfolio of branded products moving to market.
  • J3 Holdings – The signing of a letter of intent to acquire J3 Holdings includes the company’s land and warehouse, as well as a license to cultivate hemp and refine it into usable forms. Neutra has concentrated its early efforts developing business networks and on developing hemp-based CBD products, including supplements and creams. The latest move will enable the company to grow its own hemp supply, giving it more control over the quality of its ingredients.

Partners

  • Surface to Air Solutions is the North American distributor of a patent-pending, water-based solution known as Purteq, a green technology that works similar to photosynthesis.
  • ZeroBlast uses a durable, non-toxic, anti-microbial solution to eliminate all contaminates and kill germs on contact for a period of up to 90 days.

Leadership

Neutra president and CEO Sydney Jim provides strong executive leadership, a network of business contacts and experience implementing solid corporate strategy. Jim has a proven track record of adding value for public company shareholders. He founded Global Visionary Investments where operational support is provided to seven different companies and their subsidiaries. Jim was also the CEO of First Titan Energy, a microcap public company where he was responsible for restructuring the corporate structure, deal sourcing, and leading the company in mergers and acquisitions.

Dr. Scott Cherry is the company’s sports performance medical advisor. He is an energetic physician executive with a passionate focus on health, performance and prevention. Dr. Cherry received emergency medical technician training in the U.S. Navy, a bachelor’s degree in chemistry from Florida State University, medical degree from Nova Southeastern University, and a master’s degree of public health from Uniformed Services University F. Edward Herbert School of Medicine. Dr. Cherry has honed his skills in a variety of medical and executive positions spanning the U.S. Army and Navy, several Fortune 500 corporations, and major health care facilities over the past 20 years.

Neutra Corp. (OTCQB: NTRR), closed Thursday's trading session at $0.001, up 11.1111%, on 46,920,262 volume with 151 trades. The average volume for the last 3 months is 30,224,914 and the stock's 52-week low/high is $0.0006/$0.07.

Recent News

chart

Geyser Brands Inc. (TSX.V: GYSR)

The QualityStocks Daily Newsletter would like to spotlight Geyser Brands Inc. (TSX.V: GYSR).

The Yield Growth Corp. (CSE: BOSS) (OTCQB: BOSQF) (FSE: YG3) is pleased to announce that it has signed a non-binding letter of intent to enter into a co-packing agreement with Apothecary Botanicals, a Canadian licensed cannabis producer and subsidiary of Geyser Brands Inc. (TSXV: GYSR), for the production and launch of Yield Growth's Canadian Cannabis brand Jack n Jane, a line of cannabis-infused products including tinctures, topicals and capsules. Also today, the company was highlighted in the Investor Ideas Potcast, from Investorideas.com. Listen to the podcast: http://ibn.fm/tNBqO

Geyser Brands Inc. (TSX.V: GYSR) is a consumer wellness brand cultivator that builds and markets hemp-infused health and wellness products and brands in the nutraceutical, cosmetics, food and beverage and pet sectors. Using its proprietary nanotechnology formulation, the company delivers creams, baked goods and tincture formulations with superior bioavailability and water solubility. Geyser Brands is rapidly building its revenue-generating operation with a marked milestone in September 2019 with the successful acquisition of Solace Management, a company whose portfolio includes 57 SKUs of consumer wellness goods and pet care products.

Solace recently moved into its new 7,500-square-foot GMP (Good Manufacturing Practices)-compliant facility in Coquitlam, British Columbia, which is expected to trigger up to a 10-fold increase in the company’s production capacity now that it has a Natural Health Product site license from Health Canada. Solace intends to also develop and license new products that are either ready for production or are in various stages of development, since construction of the facility is now complete.

Geyser Brands and Solace welcomed yet another marketable product to their stable with the receipt of an NPN (Natural Product Number) from Health Canada for their hemp-based pain relief roll-on, which means the pain-relief product can now be sold as a natural health product through the company’s Apothecary Naturals line. Health Canada assessed the roll-on and found it to be safe, effective and of high quality when it is used as directed.

NanoFusion Technology

The efficacy of most hemp products is restricted as the insoluble nature of the molecules prevents most of the product from permeating the skin or entering the body system. Geyser Brands solves this insolubility problem with an advanced delivery system that quickly and efficiently transports therapeutic agents directly to the bloodstream for maximum absorbency.

Made with all-natural materials, NanoFusion technology offers an array of advantages: enhances penetration for deeper skin penetration; improves the transport of active ingredients for site-specific targeting; delivers active ingredients across cell membranes for release within the cell; and provides longer shelf-life and stability of molecules.

Operations

Geyser Brands operates a 7,000-square-foot facility in Port Coquitlam, British Columbia, where its initial cannabis cultivation generated the first revenues out of the company’s cultivation license granted in October 2018. Geyser Brands is approved as a licensed producer in compliance with Health Canada standards, which allows the company to pursue its processing and sales license. Obtaining this license will enable the company to extend its products and brands into the regulated Canadian cannabis market and directly to the consumer medical market.

Geyser Brands’ integrated production chain and formulation lab develops innovative products using high-quality hemp for healthy lifestyle brands while its R&D lab produces product formulations designed to enhance bio-availability of hemp and shelf stability while maintaining all-natural ingredients and ensuring premium quality.

Geyser Brands actively explores opportunities to invest in the research and development of unique, high-quality proprietary strains and technologies that target specific health-related conditions such as pain and inflammation reduction, insomnia, digestive issues and other commonly known ailments.

Growing Portfolio

  • Apawthecary Pets – line of products has established itself as leading all-natural hemp-based pet treats with formulations for pet treats, salves and oral drops. Animals, like humans, may suffer from the insomnia, digestive difficulties, pain and inflammation hemp products are designed to relieve a wide variety of conditions. All of Apothecary’s products are made with organic, cold-pressed and unrefined hemp seed oil extract.
  • Apothecary Naturals – 100% all-natural, organic, hemp-based topical products for everything from skin care to pain relief.
  • WildTails – 100% all-natural, freeze-dried, single-ingredient and nano-hemp infused pet foods and treats.
  • Apothecary Ink – Antibacterial skin preparation products, pain control as well as skin care for new and old tattoos.

Management Team

Chairman and Co-Founder, Brad Kersch, brings a strong business background with over 20 years of experience in successful startups and working with Fortune 500 companies. He spent his early years in the advertising and marketing field and went on to form Hyperware, a clothing company that sold branded clothing to retailers across Canada before selling to clothing giant Ocean Pacific (OP). Kersch became the president of Shoreline Studios, Canada’s largest and oldest studio for film and TV. In 2014 he started Solace Management Group, a hemp product company focused on pet, cosmeceutical, and nutraceutical markets.

CEO and Co-Founder, Andreas Thatcher, has been CEO of Geyser Brands since the January 2018 and has been a principal at Rhizome Group since 2014, an entertainment company focused on building media IP through creative and market development. He previously was a founding partner at Rhizome Capital LLC, a U.S.-based media investment company specializing in marketing and distribution financing, and worked in the Investment Banking industry in London and Toronto. Thatcher holds a master’s degree in economics.

CFO Gordon Clissold is a Chartered Professional Accountant with over 20 years of experience as an operational and financial manager for both public and private companies. His career experience spans multiple industries that include technology, manufacturing, wholesale distribution, and professional services. Gordon obtained his accounting designation in 1995, was awarded the Fellowship designation in 2006, and has been awarded life membership as Chartered Professional Accountant.

Kuldip Gill, head of Geyser Brands’ R&D program, has more than 35 years of experience in the cannabis industry. Gill built the largest manufacturing facility in the lower mainland in Surrey, British Columbia, complete with R&D, analytical and quality control labs approved by both the FDA and Health Canada. He has to date created over 3,500 formulas, most notably Lakota pain relief gel. Gill’s experience and proven track record is evident in the strongly marketable formulations he has developed and sold worldwide.

Geyser Brands Inc. (TSX.V: GYSR), closed Thursday's trading session at $0.38, even for the day, on 28,000 volume with 4 trades. The average volume for the last 3 months is 2,072 and the stock's 52-week low/high is $0.349999994/$0.850000023.

Recent News

chart

Quest Patent Research Corp. (OTCQB: QPRC)

The QualityStocks Daily Newsletter would like to spotlight Quest Patent Research Corp. (OTCQB: QPRC).

New York City-based intellectual-property (“IP”), asset-management firm Quest Patent Research (OTCQB: QPRC), through its majority-owned and controlled subsidiary Quest NetTech, filed a lawsuit on against Apple Inc. on April 12, 2019, alleging willful and deliberate infringement of US RE38,137. To view the full article, visit http://nnw.fm/2RqWB.

Quest Patent Research Corp. (OTCQB: QPRC) is a New York City-based intellectual property (IP) asset management firm operating through majority-owned and controlled operating subsidiaries to deliver financial, strategic and legal resources for IP monetization. Quest currently owns, controls or manages over 115 patents across 11 intellectual property portfolios (https://www.qprc.com/portfolio). The company generates revenues from patent licensing fees of its IP property portfolios and from licensed packaging sales.

Quest creates shareholder value through investment and management interests in intellectual property assets, such as patents, trademarks, copyrights, novel inventions and trade secrets. Through its business, shareholders have the opportunity to participate across a broad portfolio of dynamic assets in the burgeoning intellectual property space.

Objectives

Invention, protection and commercialization of IP require a deep understanding of dynamic technologies, market fundamentals, competitive landscapes and engagement strategies. Often, IP asset owners/stakeholders lack the requisite resources, experience and/or capacity to access the latent value of their IP assets and opportunities. Quest seeks to bridge this gap, partnering with asset owners – such as inventors, businesses, corporations and law firms – to help them fully realize the value of IP assets through:

  • IP Valuation
  • Structured Licensing Programs
  • Patent Prosecution
  • Partial or Full Liquidity
  • Portfolio Evaluation
  • Portfolio Maintenance
  • Legal Advisory
  • Attorney/Investor Referral
  • Patent Acquisition/Liquidation

At Quest, each partnership is treated as its own entity, with its own focused management comprised of Quest employees and seasoned industry associates. Many of technologies are placed in a wholly owned subsidiary of Quest, benefitting from the broader expertise of the company’s leadership.

Management

Quest’s management team delivers a wealth of experience in strategic business management, intellectual property, finance and marketing. The company’s internal resources, in tandem with its external network of financial, legal and managerial professionals, can develop creative solutions to the myriad of challenges involved in monetizing IP. Quest’s structured diligence and deployment procedures mitigate risks, maximize returns and deliver value to IP owners and shareholders alike.

Quest CEO and President Jon Scahill was the founder and managing director of the Urban-Rigney Group, LLC, a private consultancy specializing in new business/new venture development, operations optimization, and strategic analysis. Prior to launching his consultancy business, Mr. Scahill held numerous positions in sales and marketing, technical management, and product development in the consumer products/flexible packaging arena. Mr. Scahill holds a B.S. in chemical engineering from the University of Rochester, an MBA from Rochester’s Simon Graduate School of Business, and a JD from Pace University Law School. He is a registered patent attorney admitted to practice in New York, Florida, the District of Columbia and before the United States Patent and Trademark Office.

Quest Chief Technology Officer Timothy Scahill recently completed a merger and buyout of Managed Services Team LLC, an IT Managed Services provider. Prior to Managed Services Team, he was president of Layer 8 Group Inc., which merged with Structured Technologies Inc. to form Managed Services Team LLC. In his roles he was responsible for business strategy, acquisition, execution, as well as financial management. Mr. Scahill’s entrepreneurial acumen and proven record of successful management with sole discretionary responsibility, demonstrate the scope of his capability and his value to delivering results. He successfully completed his term on the boards of the Upstate New York Technology Council and Pariemus Rochester. Mr. Scahill completed a six-year term as secretary, executive council and a seat on the board of directors for Habitat for Humanity. He has served as president of the Western New York chapter of The Entrepreneurs Organization and continues to serve on the board as accelerator chair. Mr. Scahill is currently performing Cyber Intelligence, Security and Information Assurance work for an undisclosed organization.

Peter LaFauci is president of CFO Solutions, a Rochester, NY-based consulting firm offering knowledge-based financial and accounting solutions for emerging to medium-size companies. Mr. LaFauci is a seasoned executive with over 25 years of proven success in developing, leading and executing strategy in both publicly and privately held companies within the advertising, software development, internet, manufacturing and emerging technologies sectors. Peter possesses strong research and analytical skills as well as interpreting, summarizing and communicating financial and business information to others. Mr. LaFauci is a graduate of Saint Bonaventure University.

Quest Patent Research Corp. (OTCQB: QPRC), closed Thursday's trading session at $0.014, even for the day, on 239,073 volume with 8 trades. The average volume for the last 3 months is 292,425 and the stock's 52-week low/high is $0.001799999/$0.039999999.

Recent News

chart

CloudCommerce (OTCQB: CLWD)

The QualityStocks Daily Newsletter would like to spotlight CloudCommerce (OTCQB: CLWD).

Business data technology company CloudCommerce Inc. (OTCQB: CLWD)is welcoming a new client to its family of data, messaging and digital marketing services under an agreement that will be effective over the next 12 months. Insurance and investment powerhouse Starr Insurance Companies is asking CloudCommerce to help drive incremental sales growth by leveraging CloudCommerce’s digital marketing channels, drawing on the core capabilities of its wholly owned subsidiaries.

CloudCommerce (OTCQB: CLWD) is a leading provider of audience-driven business intelligence and marketing solutions. Together with its wholly owned subsidiaries, CloudCommerce delivers invaluable end-to-end business intelligence and marketing solutions through a range of services and capabilities.

Flagship Solution

SWARM is an end-to-end solution that applies advanced data science, behavioral science, artificial intelligence and market research techniques to deliver powerful audience-driven business intelligence that converts opportunities into business success.

Through marketing, brand perception, customer-relationship management, human-resources management and operational logistics applications, CloudCommerce’s SWARM solution helps businesses determine who to talk to, what to say and how to motivate targeted audiences to take meaningful action.

The Market

Marketers have largely taken a blanket approach to communication. The same messages are often sent across an entire customer audience with little regard for how different groups of people communicate, build communities and develop their purchasing habits. When marketers do segment audiences, they use objective selection criteria such as income, geography, education or purchase history to deduce attitudes or intentions.

However, research shows that motivations and feelings are much more accurate at predicting behavior. The challenge for businesses is that these factors are also the hardest to gather from audience data. CloudCommerce provides that audience-intelligent data through SWARM, its proprietary behavioral-science approach to audience creation and communication. Through SWARM, CloudCommerce helps marketers identify consumer motivations and triggers in order to effectively predict and influence actions. When companies influence action, they can change opinions, gather support, motivate purchases and inspire change.

In a fast-developing global business intelligence market estimated to grow from $16.3 billion in 2016 to $34.3 billion by 2022, CloudCommerce stands apart as an innovator and true partner, able to deliver data-driven intelligence and solutions that enable its customers to strengthen their brands, deliver their messages and reach their goals.

SWARM Products

THE SWARM—Intelligent Audience Building
The core of the CloudCommerce solution – and what separates CloudCommerce from other audience data companies – is the company’s unique approach to audience building. The concept of “personas” has been around for decades, but CloudCommerce takes that concept to the next level. The SWARM was developed to identify not only who to talk to but also what to say in order to motivate target audiences to take meaningful action. Using CloudCommerce’s proprietary clustering and behavioral analysis techniques, businesses can identify target audiences and deliver messages that are more focused and efficient. CloudCommerce not only helps its client partners find the right people to talk to but also identifies the most powerful message to send.

BUZZ—Behavior-Based Market Research
Market research is evolving. Research techniques developed and used today are more sophisticated and backed by strong data science. Despite these changes, many traditional research firms have failed to innovate: small sample sizes, survey design bias, improper weighting and gut-intuition sampling are just some of the issues that plague the market-research industry. Through BUZZ, CloudCommerce has automated the market research process to provide a level of statistical depth beyond what traditional firms can offer. BUZZ offers businesses the ability to put their finger on the pulse of the marketplace in the moment. Using a wide range of internal and external data sources such as customer data, social media activity, and micro and macro trends, BUZZ deduces attitudes, emotions and opinions.

HIVE—Redefined Geographic Targeting
Conventional geographic audience targeting is outdated. Arbitrary units of location such as counties, cities, DMAs and regions were created centuries ago based on land-rights ownership. Their use in understanding people’s behavior, purchase habits and underlying values is minimal. CloudCommerce has found a much more powerful, efficient and effective way of targeting by clustering people into granular geographic tribes called HIVES. HIVES are defined by attributes such as common language (e.g., colloquialisms), shared experience and narratives (e.g., climate, history), and concentrated demography and biology (e.g., ethnicity, age). Based on the needs of its clients, CloudCommerce can completely redraw the geographic lines based on various Hive selection criteria. Using this exclusive HIVE approach, CloudCommerce clients experience more efficient and effective marketing, make more intelligent business decisions and enjoy more growth.

HONEY—Advanced Reporting and Visualization
Advanced-audience, data-analysis technologies are useless if they don’t produce simple, powerful and actionable business intelligence. HONEY comes with user-friendly reporting and visualization tools to organize and explain all of the advance-data science into a simple-to-understand format for decision makers. HONEY combines the intelligence of client CRM data with third-party consumer data and targeted market research to create a powerful foundation for any audience-intelligence solution.

Subsidiaries

Data Propria
Data Propria delivers the highest Return on Investment (“ROI”) for their customers’ digital marketing campaigns, by utilizing sophisticated data science to identify the correct universes to target relevant audiences. Their ability to understand and translate data drives every decision they make. By listening to and analyzing their customers’ data they are able to make informed decisions that positively impact their customers’ business. Data Propria leverages industry-best tools to aggregate and visualize data across multiple sources, and then their data and behavioral scientists segment and model that data to be deployed in targeted marketing campaigns. They have data analytics expertise in retail, wholesale, distribution, logistics, manufacturing, political, and several other industries.

Parscale Digital
Parscale Digital helps their customers get their message out, educate their market and tell their story. They do so creatively and effectively by deploying powerful call-to-action digital campaigns with national reach and boosting exposure and validation with coordinated advertising in print media. Parscale Digital’s fully-developed marketing plans are founded on sound research methodologies, brand audits and exploration of the competitive landscape. Whether their customer is a challenger brand, a political candidate, or a well-known household name, Parscale Digital’s strategists are skilled at leveraging data and creating campaigns that move people to make decisions.

Giles Design Bureau
Giles Design Bureau approaches branding from a “big picture” perspective, establishing a strong identity and then building on that to develop a comprehensive branding program that tells the customer’s story, and articulates what sets the customer apart from their competitors and establishes the customer in their market.

WebTegrity
WebTegrity develops commerce-focused, user-friendly digital websites and apps that elevate their customer’s marketing position and draw consumers to their products and services. Their platform-agnostic approach allows WebTegrity to architect and build solutions that are the best fit for each customer. Once the digital properties are built, their experts will help manage and protect the website or app and provide the expertise needed to scale the infrastructure needed as the customer’s business grows.

Leadership

Andrew Van Noy, CEO & Chairman of CloudCommerce Board of Directors
Andrew Van Noy has been a director of CloudCommerce since November 2012, president of the company since April 2012, and the CEO of the company since August 2012. He also served as executive vice president of CloudCommerce from November 2011 to April 2012 and vice president of Sales and Marketing of the company from May 2011 to November 2011. From January 2009 to April 2011, Van Noy served as the vice president of Sales and Marketing for PageTransformer, which provided web and software development for iPad, iPhone and Android devices. Van Noy came to CloudCommerce with experience in digital marketing, private equity and investment banking. During his years at the company, Van Noy led the efforts to rebrand and restructure the business and presided over the acquisition of a number of companies. Van Noy graduated from BYU with a Bachelor of Science degree.

Gregory Boden, CFO and Board of Directors
Gregory Boden became a director at CloudCommerce in November 2011 and in February 2013 was named corporate secretary. In April 2012, Boden was also appointed CFO. In addition, Boden is the managing partner of a private equity company. Prior to joining the CloudCommerce team, Boden managed the franchise accounting and cash application departments of Select Staffing, a nationwide staffing company and was an accountant at KPMG LLP. Boden earned his master of accountancy degree from the University of Denver.

Brad Parscale, Board of Directors
Brad Parscale creates web-marketing strategies and oversees all technical and functional aspects of these strategies. Originally from Kansas, Parscale spent five years in California before moving to San Antonio in 2004 to establish Parscale Media, a successful web-marketing firm. His 2011 partnership with Jill Giles formed Giles-Parscale Inc. In 2016, Parscale was named digital director for the Donald J. Trump presidential campaign.

Zachary Bartlett, VP of Corporate Development and Board of Directors
Zachary Bartlett has been a director of the company since July 2012 and was appointed vice president of Corporate Development in January 2018. Bartlett has also served as vice president of Communications and an independent contractor assisting with project management matters. Prior to joining CloudCommerce, Bartlett was the creative director at Crowbar Studios Inc., a graphic design and web development firm he founded in 2008. From 2004 to 2008, he held the position of art and brand consultant at Demon International, a snowboard accessories company. Bartlett earned his bachelor of fine arts degree in graphic design from Brigham Young University.

CloudCommerce (OTCQB: CLWD), closed Thursday's trading session at $0.003, even for the day, on 1,578,577 volume with 12 trades. The average volume for the last 3 months is 1,052,881 and the stock's 52-week low/high is $0.0027/$0.0228.

Recent News

chart

HTC Extraction Systems (TSX.V: HTC)

The QualityStocks Daily Newsletter would like to spotlight HTC Extraction Systems (TSX.V: HTC).

HTC Extraction Systems (TSX.V: HTC) today announced that it has repriced its "bought deal" brokered private placement initially announced on July 3, 2019 and amended on September 27, 2019. According to the update, the repricing of the private placement more accurately reflects the current market price of the company's common shares. To view the full press release, visit http://cnw.fm/PuWf4. Also today, the company was highlighted in a publication from CBDWire, examining how CBD has built quite a reputation in the few years it has been mainstream. The list of diseases CBD has in the past proven effective against spans from minor conditions such as anxiety and inflammation to severe ones like chronic pain and epilepsy. At this point, it’s anyone’s guess what else cannabidiol works against.

HTC Extraction Systems (TSX.V: HTC) has developed and optimized proprietary technologies designed for biomass extraction, distillation and purification of ethanol and ethanol-based solvents used for the hemp biomass and cannabidiol (“CBD”) industry, as well as gas and liquid extraction. HTC’s extraction & purification systems are engineered to large-scale to reduce capital and operating costs while delivering superior performance measured by reduced energy usage, lowered emissions and improved quality of the product produced.

Advanced Extraction Technologies

For more than 14 years, HTC has developed and optimized proprietary technology and purification systems used for biomass, gas and liquid extraction. These technologies include:

  • LCDesign® – Low-cost design for modular gas, liquid and biomass extraction systems optimizes plant design, thus reducing capital and operating costs.
  • PDOEngine™ – Software-based design algorithms accurately model and simulate gas, liquid and biomass extraction processing.
  • Delta Solvents™ – Custom-designed, ethanol-based solvent mixtures and additives that optimize production and reduce costs. Technology development is being conducted at HTC’s sponsored research facilities at the University of Calgary.

Delta Purification® Technology

HTC’s patented Delta Purification® technology will purify, recycle and reuse the extraction ethanol used in the CBD extraction process while managing and reducing any CBD waste losses through the re-extraction of all wastes collected from the purified ethanol. Current and new technologies include:

  • Delta CBD Reclaiming System: Reclaiming and purifying ethanol for use in CBD extraction from biomass. Reduces required heat to prevent damage of the chemical attributes of the CBD molecule, allowing extracted CBD to meet food-grade targets for human consumption.
  • Delta Solvent Reclaiming System: Reclaiming and purifying ethanol-based solvents, such as single, mixed and formulated amines, for use in natural gas processing and post-combustion CO2 capturing processes.
  • Delta Glycol Reclaiming System: Reclaiming and purifying glycols, such as mono-ethylene glycol and tri-ethylene glycol for use in natural gas dehydration processes.

Hemp Biomass and Tolling Contracts

HTC has entered into a hemp biomass tolling agreement for the 2019 crop year involving a supply of hemp biomass from a hemp grower in Saskatchewan, Canada. The hemp grower utilizes five varieties of Health Canada-approved cultivars as the genetic foundation. HTC will process and extract CBD FSO distillate from the hemp biomass. As a tolling fee payment, HTC will receive a percentage of the extracted CBD FSO distillate for its processing, extraction, purification and distillation services.

Additional hemp biomass tolling contracts with producers and hemp biomass providers are being negotiated in the U.S. for the 2020 hemp crop growing year. HTC will provide “local-to-grower” drying-to-biomass storage capability and transportation of dried biomass to an HTC, location to be determined, future US based, extraction facility. HTC is also in negotiation with a 60,000-acre, recognized Canadian farm leader, who is a significant hemp biomass producer, for a similar hemp biomass tolling contract.

re3™ Technology

Large users of ethanol and solvents for plant oil extraction demand reduced capital and operating costs. HTC’s re3™ (reclaim, recycle, reuse) technology can save up to 30% of the required fluid costs. The increasing cost of new extraction ethanol, combined with the cost of used ethanol disposal, creates a unique opportunity whereby the re3™ technology will create cost savings, while meeting environmental responsibilities.

The growth of ethanol and CO2 used in CBD production has created a new demand for reliable commercial scale ethanol reclaimer systems. The Delta Purification® ethanol system meets this new demand.

Sales and Offtake Agreements

HTC intends to leverage its relationship with its related entity, Purely Canada Foods™, to provide sales and distribution for its Ingredient CBD market under the brand of Purely Canada Hemp™, Purely Canada CBD™, Purely Canada Cannabinoids™. Purely Canada Hemp™ will develop risk managed multi-year ingredient supply contracts with its existing and new Global Food, Beverage and Animal Food Industry Customers.

Project Construction

HTC has focused the Canadian implementation of its BOOM (build, own, operate and maintain) extraction tolling strategy on a location near Regina, Saskatchewan. HTC is currently constructing a 19,000-square-foot GMP Euro compliant extraction tolling facility on six acres of land that will include biomass processing, extraction, implementation of DeltaSolv™ technologies and Delta Purification® systems, distillate and refining equipment, laboratory quality control and testing operations, and on-site office and admin facilities.

Leadership

Chairman, CEO and Director Lionel Kambeitz is a recognized professional in business development and international business relations. He has played a founding role in many other Canadian and U.S.-based companies. Kambeitz has executive experience in a variety of industries including energy, agriculture, food production engineering, and manufacturing.

Jeff Allison, Senior Vice President, Chief Financial Officer and Director, has over 20 years of experience in corporate finance and business development. Prior to joining HTC in 2005, Allison as Vice President assisted with the founding and setup of CUCORP Financial Services in Saskatchewan.

HTC Extraction Systems (TSX.V: HTC), closed Thursday's trading session at $0.475, off by 1.0417%, on 9,500 volume with 5 trades. The average volume for the last 3 months is 104,401 and the stock's 52-week low/high is $0.079999998/$1.24.

Recent News

chart

MustGrow Biologics Corp. (CSE: MGRO)

The QualityStocks Daily Newsletter would like to spotlight MustGrow Biologics Corp..

MustGrow Biologics (CSE: MGRO) (OTC: MGROF), an agricultural biotech company developing and commercializing a portfolio of natural, science-based bio-pesticides and bio-fertility products, this morning announced the finalization of its advanced liquid formulation. To view the full press release, visit http://cnw.fm/6vOeR.

MustGrow Biologics (CSE: MGRO) is an agricultural biotech company focused on developing and commercializing its patented technology that is a natural biopesticide and biofertilizer for use as a fertilizer, nematicide, pesticide and fungicide. MustGrow’s novel and proprietary solutions utilize organic components refined from mustard seed to provide high quality, organic pest control to growers facing challenges associated with soil-borne diseases and pests such as nematodes. The company’s technology provides an all-natural, effective, safe and easy-to-use solution for farmers seeking to raise healthy crops without the use of pesticides.

Nematodes, or microscopic worms, are the most numerous multicellular animals on earth. A handful of soil will contain thousands of nematodes, many of which are parasites of insects, plants or animals. Most plant-parasitic nematodes feed on the roots of plants, damaging the root system and reducing the plant’s ability to absorb water and nutrients (http://nnw.fm/Qkz21). For the past 50 years, nematodes have been controlled using chemical nematicides, but the Environmental Protection Agency now restricts or bans many of the chemical?formulations.

MustGrow’s technologies provide nematode control that is equal and often superior to synthetic alternatives, resulting in elevated yields and increased returns for the grower. The global economic impact of soil-borne nematodes is estimated at nearly $100 billion in lost crops per year. The American Phytopathological Society (http://nnw.fm/3HGuT), an international nonprofit scientific organization dedicated to the study and control of plant diseases, estimates that plant-pathogenic nematodes are responsible for 14 percent of crop losses worldwide.

MustGrow’s technology refines mustard seeds to concentrate the plant’s natural organic compounds that form Allyl isothiocyanate (“AITC”), which serves the plant as a natural defense system against pests and diseases. As a result, MustGrow’s novel product offers first-class performance, is 100 percent natural, and its fertilizer product is listed for organic use by the Organic Materials Review Institute (“OMRI”) under specifications set by the USDA’s National Organic Program.

MustGrow’s initial technology was a granular pre-plant soil biofumigant and biofertilizer containing the active ingredient AITC, a proven nematicide, fungicide and fertilizer. The company has completed 110 independent third-party field trials on fruit and vegetable crops. As a biofertilizer, MustGrow’s product is registered with Health Canada and the EPA in all U.S. states as OMRI-certified. It is also registered for use as a biopesticide by the EPA in key fruit and vegetable growing U.S. states (except California) and with Health Canada. MustGrow is finalizing a new liquid delivery platform with increased concentration of the same active ingredient (AITC) that can be applied through drip lines to meet the demands of today’s growers.

Results of tests completed to date show that MustGrow continues to provide innovative solutions with broad based applications within agriculture. Validated field trial results include:

  • 100 percent control of root-knot nematodes in strawberry crops as compared to methyl bromide
  • 55 percent tomato crop yield increase
  • 95 percent control of Pythium root rot in lettuce fields
  • 70 percent reduction in Verticillium root severity in cucumbers
  • Market Opportunity

Market Opportunity??

MustGrow is also testing the potential application of its technology to the cannabis industry, which is projected to grow to nearly $22 billion in the U.S. by 2020. While there are no uniform guidelines for pesticide use in the cannabis industry, state-by-state regulations in the U.S. do exist which has led to instances of pesticide-tainted cannabis showing up in tested products, leading to recalls and threats of lawsuits. Health Canada recently published regulations for mandatory testing for pesticides in cannabis that are now in effect for all growers.?MustGrow’s?potential application for cannabis production shows that when its product is used as a pre-plant/pot soil treatment, it may significantly help control many soil-borne diseases, pathogens and pests, including nematodes, fusarium, rhizoctonia, and botrytis (gray mold) that affect the cannabis plant. Cannabis consumers are increasingly demanding organic products free from chemicals and have shown they are willing to pay a premium for high-quality organic cannabis. MustGrow is currently running cannabis soil trials and is seeking Health Canada approval for use of its product on cannabis.?

Global crop protection is a multibillion-dollar market that is expected to surge over the next five years. Sales of nematicides are set to grow by 33 percent to $1.43 billion by 2022, while biopesticides are projected to leap by 94 percent to an estimated?$9.5 billion by 2022. MustGrow is targeting the global nematicide industry with products that include an innovative pre-plant soil treatment. Solutions for the global biopesticide industry include seed treatment technologies, fungicides and nematicides.??

MustGrow’s groundbreaking technologies use novel plant compounds to provide superior crop protection naturally.

Management Team

President and CEO Corey Giasson is an entrepreneur with more than 20 years in the agriculture, potash, oil and gas, mining and real estate industries.? Mr. Giasson co-founded Rallyemont Energy Inc., a heavy oil company that successfully identified 140 million barrels of recoverable heavy oil, that was sold in 2013 to Husky Energy. He holds an MBA and bachelor’s degree in agricultural economics from the University of Saskatchewan.

Chairman Brad Munro has 20-plus years as a vice president/investments, with a national venture capital firm where he sourced, invested and managed the activity of over 30 companies and invested $150 million. He has served as a director of over 20 public companies and a greater number of private enterprises. Munro is currently director of Secure Energy Services.

COO Colin Betsky is the previous vice president/BioAg at Novozymes, where he was responsible for the company’s BioAg business worldwide. He holds a bachelor’s degree in agriculture from the University of Saskatchewan and has more than 20 years of experience in agricultural chemicals and biologics.

Director Tom Flow is the founder and current president of The Flowr Corporation (TSX.V: FLWR) and Licensed Producer of cannabis in Canada. He founded and built MedReleaf, Canada’s most profitable Licensed Producer which was later acquired by Aurora Cannabis?(TSX: ACB) (NYSE: ACB) for $3.2 billion. Flow is widely recognized for his leadership and expertise in building and operating cannabis cultivation facilities.

Director Matt Kowalski has a tremendous amount of experience in the fruit and vegetable and biologics industries. Under his leadership at Natural Industries, a business focused on biological pest control, the company was awarded five EPA registrations: three biofungicides, a bionematicide, and a bioinsecticide. In November 2012, Kowalski led the strategic sale of Natural Industries to Novozymes BioAg. He is the principal owner of Stronghold Keep Inc., an investment corporation.

CFO Todd Lahti has extensive experience evaluating and managing start-up companies in the biotechnology, agricultural and oil and gas sectors, working directly on financing transactions, mergers and acquisitions, corporate strategy, business development, technology transfer and operations set up. He is a Chartered Financial Analyst and a Chartered Professional Accountant.

MustGrow Biologics Corp. (CSE: MGRO), closed Thursday's trading session at $0.30, off by 3.23%, on 6,182 volume with 3 trades. The average volume for the last 3 months is 39,640 and the stock's 52-week low/high is $0.25/$0.699999988.

Recent News

chart

ChineseInvestors.com (CIIX)

The QualityStocks Daily Newsletter would like to spotlight ChineseInvestors.com (CIIX).

Established financial news and investment portal for the global Chinese-speaking community ChineseInvestors.com (OTCQB: CIIX) today announced its financial and operational summary for the first quarter of its fiscal year 2020. To view the full press release, visit http://cnw.fm/b3oX3.

Founded in 1999, ChineseInvestors.com (CIIX) has become a leading financial information website for Chinese-speaking investors in the United States and China. Recognizing unprecedented opportunities in the U.S. cannabis industry, CIIX is also laying the groundwork to capitalize on growing demand for cannabidiol (CBD)-based nutrition and health products.

Through its primary website, www.ChineseInvestors.com, CIIX offers a variety of investor education products and services, including real-time market commentary, analysis and educational related services in Chinese language character sets; consultative services to smaller private companies considering becoming a public company; and advertising and public relations related support services.

At the center of this initiative is the ChineseInvestors Method, a unique integration of a disciplined investing process, web-based tools, personalized instructions and support. Using this strategy, CIIX provides reliable market information to help investors make informed investment decisions and meet their individualized financial goals.

CIIX is also leveraging its financial expertise to enter into the burgeoning CBD industry, which within a few years has grown from a relatively invisible sector to a billowing market expected to reach $2.1 billion in consumer sales by 2020.

The increasing demand for CBD-based products is a catalyst for innovative business endeavors. To this accord, CIIX has established a three-year development plan to capitalize on the convergence of CBD and the nutrition and health products market in mainland China, where the benefits of CBD oil have not been widely recognized.

Under a wholesale agreement with a reputable CBD health brand, CIIX is launching the world’s first online CBD health products store published in the Chinese language. The site, www.ChineseCBDoil.com, caters to a growing number of Chinese people awakening to the numerous health benefits of CBD oil for treatment of a variety of conditions such as anxiety, stress, poor sleep, Alzheimer’s disease, and more. CIIX expects to launch this website at the end of January 2017, and plans to sell CBD-infused products via online and in-store.

In conjunction, CIIX’s cannabis-focused “Yelp”-style mobile app is in development as a platform for Chinese people to review and discuss various cannabis products. The app will be the first marijuana social media mobile app designed for Chinese-speaking customers worldwide.

ChineseInvestors.com (CIIX), closed Thursday's trading session at $0.2575, off by 0.386847%, on 24,450 volume with 16 trades. The average volume for the last 3 months is 42,301 and the stock's 52-week low/high is $0.239999994/$0.959999978.

Recent News

chart

IONIC Brands Corp. (CSE: IONC) (OTC: IONKF)

The QualityStocks Daily Newsletter would like to spotlight IONIC Brands Corp. (OTC: IONKF).

IONIC Brands (CSE: IONC) (OTC: IONKF) (FRA: IB3), a West Coast cannabis holding company, is focused on exploiting the adult-use cannabis industry by finding where the market is and anticipating where it’s going, especially in regards to technology. To view the full article, visit http://cnw.fm/0TrPi.

IONIC Brands Corp. (CSE: IONC) (OTC: IONKF) is a national cannabis holding company building a multistate portfolio of award-winning premium and luxury brands in the cannabis space. Established in 2015, IONIC Brands has demonstrated its ability to expand and operate multiple cannabis concentrate consumer brands in leading markets across the western United States, with current operations in Washington, Oregon, California and Nevada. The company continues to strategically expand nationwide to remain a leader of the highest-value segments in the cannabis market.

With a focus on quality, responsibility and respectability, IONIC’s product lines are pioneering the changing landscape of cannabis consumption. The company’s refinement practices are a result of a passionate commitment to craft the finest, small-batch cannabis oils and cannabis concentrates in the world – without glycols, glycerins or additives.

IONIC’s Certified Clean program verifies that every product leaving the company’s facilities meets or exceeds state mandates on pesticide testing. The testing is conducted by individually testing every batch which ensures and enhances trust and transparency. IONIC recently paired its Certified Clean program with Lucid Green Inc. and its revolutionary technology platform designed to provide vital safety information. Lucid Green’s technology provides a direct-to-consumer data platform, providing instant access to a library of product specific insights by simply scanning the package’s QR code with a smartphone camera.

Elite Brand Portfolio/Acquisitions

  • IONIC, the company’s flagship recreational branded product, is a stylish and sophisticated premium vape pen line that has earned customer loyalty and a reputation as a consistent Top 10 vape brand in Washington state. IONIC’s immediate product line expansion plans include THC/CBD mixes, low-dose products, high-end edibles, CASK oil and device innovation.
  • WW Agriculture cultivates cannabis outdoors on a 140-acre eastern Washington State farm capable of producing up to 100,000 pounds of cannabis for less than $0.10/gram.
  • ZOOTS, a Washington-based edibles company, utilizes patent-protected ultra-clean CO2 extraction hardware to create proprietary formulations of refined cannabis oils and distillates. Through MedMen dispensaries, Zoots Edibles are currently available in Washington and Colorado and will soon be on shelves at dispensaries in Massachusetts, New York and Pennsylvania.
  • Vuber Technologies hardware produces the best vaporization experience on the market.
  • Vegas M Stick vaporizer pens are distributed to stores in Washington State with plans to expand to Oregon and Nevada.
  • Vegas Valley Growers is a revenue-generating, vertically integrated operation in Las Vegas, Nevada, with a full complement of production, manufacturing and distribution licenses.

IONIC has also acquired two U.S. patents issued to Canna Café that are related to cannabinoid (CBD) infused coffee and CBD-infused coffee in a Keurig ® K-Cup ® Pod. An international patent is in process for cannabis-infused teas.

Experienced Management Team

IONIC Brands is led by an innovative product team, powerful sales organization and a world-class marketing group.

Chairman & CEO John Gorst has built and sold four different technology companies with market valuations in excess of $600 million. Gorst has been at the forefront of IONIC’s expansion and development into Washington state’s leading vaporizer brand.

Andrew Schell, President, Vice-Chairman & Co-Founder, has built several successful companies. Schell has an engineering background rounded in operations, strategy and corporate law, and most recently was CEO of a U.S. Department of Defense company specializing in military operations.

Christian Struzan, Chief Marketing Officer & Co-Founder, has over 30 years of experience in marketing and branding in the entertainment and consumer goods industries. Struzan founded an advertising agency which developed and executed marketing campaigns for feature films such as the Star Wars franchise, Fight Club, and the television series American Idol. He has also worked on global brands such as Guinness, Stella Artois and Beck’s.

Johnny Stange, Chief Revenue Officer, was formerly a director of sales for the southern California region for Treasury Wine Estates, a major wine wholesaler, where he grew and oversaw annual sales of $250 million. Stange is leading the charge in IONIC’s aggressive sales growth plans across multiple states.

In 2018, IONIC was voted one of the “Top 50 Companies to Work for in Cannabis” by MG Magazine, a publication serving cannabis industry professionals.

IONIC Brands Corp. (OTC: IONKF), closed Thursday's trading session at $0.03, off by 7.1207%, on 125,599 volume with 28 trades. The average volume for the last 3 months is 271,456 and the stock's 52-week low/high is $0.019999999/$0.634559988.

Recent News

chart

Endonovo Therapeutics Inc. (ENDV)

The QualityStocks Daily Newsletter would like to spotlight Endonovo Therapeutics Inc. (ENDV).

Endonovo Therapeutics Inc. (OTCQB: ENDV) is putting a lot of effort into the commercialization of SofPulse®, the company’s Electroceutical® wearable therapeutic device for pain management. The non-invasive, safe solution delivers pulsed electromagnetic frequencies for the effective management of pain and edema after surgery.

Endonovo Therapeutics Inc. (ENDV) develops, manufactures and distributes evolutionary medical devices focused on the rapid healing of wounds and reduction of pain, edema and inflammation on and in the human body. These wearable, non-invasive medical devices are designed to deliver the company’s proprietary, patent protected Electroceutical™ Therapy targeting inflammation, cardiovascular diseases, chronic kidney disease and central nervous system (“CNS”) disorders.

In accord with its mission to transform the field of medicine through innovation, Endonovo’s bioelectric Electroceutical™ devices harness bioelectricity to restore key electrochemical processes that initiate anti-inflammatory processes and growth factors in the body necessary for healing to rapidly occur. Endonovo’s current portfolio of commercial-stage devices address chronic kidney disease, liver disease non-alcoholic steatohepatitis (NASH), cardiovascular and peripheral artery disease (PAD), and ischemic stroke.

Flagship Therapy

SofPulse® Electroceutical ™ Therapy is an easy-to-place, non-invasive device that delivers pulsed electromagnetic frequencies to enhance post-surgical recovery. Used as a stand-alone therapy or integrated into any treatment protocol, SofPulse®’s?targeted?pulsed electromagnetic field?(tPEMF)?transmits gentle pulses to the tissue causing a positive biological effect to help reduce swelling and accelerate the body’s natural recovery process. The low levels of electromagnetic fields are completely safe and are 1000 times lower than those emitted by a mobile phone.?

Because SofPulse® lessens the pain of post-surgical recovery, the patient requires far less prescription medications, thereby minimizing or eliminating the adverse side effects of narcotics and anti-inflammatory medication. Studies have shown a greater than 2.2-fold reduction in narcotic use over the first 48 hours post-procedure. Patients with less pain and medication may move around sooner, which further stimulates the body’s natural response to healing.

Certifications

Endonovo’s Electroceutical™ Therapy is cleared by the U.S. Federal Drug Administration (“FDA”) for the palliative treatment of pain and post-surgical edema (swelling) and is CE-marked in the European Economic Area (“EEA”) for the promotion of wound healing and the palliative treatment of pain and post-surgical edema. The Centers for Medicare and Medicaid Services (“CMS”) has also certified Electroceutical™ Therapy for the treatment of chronic wounds.

Management

Alan Collier, Chairman and CEO
Alan Collier has more than 25 years of experience in corporate finance, IP development, telecommunications and technology, with a concentration in healthcare and technology over the past five years. Collier has served as CEO and director of IP Resources International Inc., where he was instrumental in developing a platform the for the licensing and acquisition of life science and technology companies. He has held numerous board and executive positions throughout his career in the telecommunications, technology, specialty finance, corporate finance and healthcare industries. Collier has previously held FINRA Series 7, 79, 63 and 24 licenses.

Michael Scott Mann, President
Michael Scott Mann has over 30 years of experience in merger and acquisitions and operational management. In 2008, Mann acquired the assets of Hanover Asset Management, now Endonovo Therapeutics Inc., and led the company to become listed on the OTCBB in 2012. He was the founder, president and CEO of Frankfurt-listed U.S. Debt Settlement Inc. (USDS), where he implemented a growth by acquisition strategy.?

Don Calabria, Chief Operating Officer
Don Calabria has over 20 years of leadership and experience in national business operations to emerging growth companies, mergers and acquisitions, finance and business development. Calabria holds an MBA from the Graziadio School of Business and Management at Pepperdine University and a bachelor’s degree from Arizona State University.

Nevena Zubcevik, Chief Medical Officer
Nevena Zubcevik, D.O., MSPT, ATC, on July 1, 2019, will lead Endonovo’s medical and clinical strategy, including the development and regulatory matters and new business development. Zubcevik, a licensed physician and educator, has more than 24 years of experience in the medical field and was an attending physician at Harvard Medical School/Partners Healthcare in the physical medicine and rehabilitation department.

Steven Ford, Vice President of Marketing
Steven Ford has 25 years of experience in the field of medical devices, including experience in sales management, product management, product development, business development and research & development at companies such as Baxter, CR Bard, Ethicon, Allergan, Mallinckrodt Pharmaceuticals and Alphatec Spine. Throughout Ford’s career, he has led and participated on over 75 product development teams and has launched over 50 medical devices globally. Ford is an innovative problem solver and has many patents in the areas of hemostasis, sealing and tissue reconstruction. Most recently, Steve was the U.S. vice president of marketing for Biom’up where he was a co-lead on the high-profile successful launch of their surgical hemostat HEMOBLAST Bellows. Steve holds a bachelor’s degree in marketing from California State University.

David Clark, Vice President of Sales
David Clark has extensive surgical device commercial experience which includes 25 years in the surgical device industry with leading companies including Medtronic and Baxter Healthcare. Most recently, Clark was the U.S. executive vice president of sales for Biom’up where he was a co-lead in the high-profile successful launch of their surgical hemostat HEMOBLAST. As part of the launch, he built and led the U.S. sales team which included over 200 in-direct sales representatives and direct commercial leadership. During his 15 years with Baxter, the BioSurgery Division grew from a small revenue business into a major market player in the advanced hemostasis space with products such as FloSeal and Tisseel. Clark has a bachelor’s degree in economics from Rutgers University.

Roc Alan McCarthy, Scientific Advisory Board Member
Roc Alan McCarthy, D.O, will help Endonovo continue to advance its clinical pipeline and contribute to the strategic and clinical development oversight of the company. McCarthy is a urologist in North Carolina, currently serving as the robotic surgeon and chairman of the robotics committee at the New Hanover Regional Medical Center.

Endonovo Therapeutics Inc. (ENDV), closed Thursday's trading session at $0.0095, off by 5.00%, on 2,157,053 volume with 34 trades. The average volume for the last 3 months is 4,426,913 and the stock's 52-week low/high is $0.006/$0.048999998.

Recent News

chart

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits

QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

ActionStockPicksAgressive StocksBetting On Wall StreetCannabisNewsWireGot Stocks?Got Stock Tips?Green Car StocksGreen Energy StocksGreen On The StreetHomeRunStocksMissionIRMissionIR MediaMissionPRMissionSMRNetworkNewsWireQualityStocks MediaQStocksQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsStock BeatsStocks To Buy NowTerrificStocksTiny GemsTip.usTouchdownStocksDaily ToutTraderPower

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.